ACAD9 (Complex I assembly factor ACAD9, mitochondrial) is a dual-function protein that serves as both a mitochondrial respiratory chain Complex I (CI) assembly factor and an acyl-CoA dehydrogenase enzyme. Its primary physiological role is as a core component of the mitochondrial complex I intermediate assembly (MCIA) complex, where it partners with ECSIT and NDUFAF1 to mediate assembly of the ND2 membrane-arm module of CI. ECSIT binding triggers a conformational change and deflavination of ACAD9, switching it from an FAO enzyme to a CI assembly factor. As a secondary/moonlighting function, ACAD9 retains FAD-dependent acyl-CoA dehydrogenase activity toward long-chain (and some medium-chain) fatty acyl-CoA substrates (EC 1.3.8.7, 1.3.8.8), catalyzing the first step of mitochondrial fatty acid beta-oxidation. Disease-causing mutations in ACAD9 result in isolated CI deficiency (MC1DN20), not primary fatty acid oxidation defects, underscoring the primacy of its assembly role. ACAD9 is a homodimer localized to the matrix side of the mitochondrial inner membrane.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0003995
acyl-CoA dehydrogenase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: ACAD9 is a bona fide acyl-CoA dehydrogenase, belonging to the ACAD family and retaining catalytic activity for the alpha,beta-dehydrogenation of fatty acyl-CoA substrates. The IBA annotation is phylogenetically inferred and well-supported by direct biochemical data from multiple publications (PMID:16020546, PMID:34646991, PMID:38086790). This is an appropriate level of specificity for the IBA evidence code.
Reason: ACAD9 has experimentally demonstrated acyl-CoA dehydrogenase activity. Purified ACAD9 shows dehydrogenation activity of 83 min-1 with palmitoyl-CoA as substrate (PMID:34646991). The IBA annotation at the general acyl-CoA dehydrogenase level is appropriate given phylogenetic support across the ACAD family.
Supporting Evidence:
PMID:34646991
As purified, the wild-type ACAD9 protein has a dehydrogenation activity of 83 min-1, attributable to the FAD-containing holo-form of the protein
PMID:16020546
Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)
|
|
GO:0003995
acyl-CoA dehydrogenase activity
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: IEA annotation based on InterPro domain mapping. ACAD9 contains the acyl-CoA dehydrogenase active site signature (IPR006089) which correctly predicts this enzymatic activity. Consistent with direct experimental evidence.
Reason: The InterPro-based IEA annotation is correct and consistent with experimental data showing ACAD9 possesses acyl-CoA dehydrogenase activity (PMID:16020546, PMID:34646991). This is a broader annotation that is subsumed by the IBA and IDA annotations but not incorrect.
Supporting Evidence:
PMID:16020546
Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates
|
|
GO:0004466
long-chain fatty acyl-CoA dehydrogenase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: IEA annotation from ARBA/Rhea mapping based on the EC 1.3.8.8 catalytic activity. ACAD9 does have demonstrated long-chain acyl-CoA dehydrogenase activity (PMID:16020546), making this a valid annotation.
Reason: ACAD9 has experimentally demonstrated long-chain fatty acyl-CoA dehydrogenase activity with substrate preference for C16-C22 chain lengths (PMID:16020546). The IEA annotation correctly captures this function and is consistent with the IDA annotation from BHF-UCL.
Supporting Evidence:
PMID:16020546
Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)
|
|
GO:0005743
mitochondrial inner membrane
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: IEA annotation based on UniProtKB/Swiss-Prot subcellular location mapping. ACAD9 is experimentally localized to the mitochondrial inner membrane, matrix side, as a peripheral membrane protein (PMID:16020546, PMID:20816094).
Reason: Multiple experimental studies confirm ACAD9 localizes to the mitochondrial inner membrane. Submitochondrial fractionation showed ACAD9 is membrane-associated (PMID:16020546). The UniProt entry explicitly states "Mitochondrion inner membrane; Peripheral membrane protein; Matrix side" with evidence from PMID:16020546 and PMID:20816094.
Supporting Evidence:
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
|
|
GO:0006631
fatty acid metabolic process
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: IEA annotation from ARBA. ACAD9 participates in fatty acid beta-oxidation by catalyzing the first step of the FAO cycle. This is a broad term and while accurate, more specific terms (long-chain fatty acid metabolic process, GO:0001676) are already annotated.
Reason: ACAD9 does participate in fatty acid metabolism through its acyl-CoA dehydrogenase activity. While this IEA term is broader than the IDA annotation to GO:0001676, it is not incorrect and is an expected consequence of the ARBA mapping.
Supporting Evidence:
PMID:16020546
Human acyl-CoA dehydrogenase-9 plays a novel role in the mitochondrial beta-oxidation of unsaturated fatty acids
|
|
GO:0016491
oxidoreductase activity
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: IEA annotation based on UniProtKB keyword mapping (KW-0560, Oxidoreductase). ACAD9 is indeed an oxidoreductase. This is a very general term but is not incorrect for an IEA.
Reason: ACAD9 is an oxidoreductase (acyl-CoA dehydrogenase, EC 1.3.8.7/1.3.8.8). While this is a very broad parent term, it is correctly applied via keyword mapping and more specific child terms are also annotated.
Supporting Evidence:
PMID:16020546
Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates
|
|
GO:0016627
oxidoreductase activity, acting on the CH-CH group of donors
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: IEA annotation based on InterPro domain mapping. ACAD9 catalyzes alpha,beta-dehydrogenation of fatty acyl-CoA, which is an oxidoreductase reaction acting on CH-CH groups. This is a correct intermediate-level term between general oxidoreductase and specific acyl-CoA dehydrogenase activity.
Reason: The acyl-CoA dehydrogenase reaction catalyzed by ACAD9 involves oxidation of the CH-CH bond at the alpha-beta position of fatty acyl-CoA substrates. This InterPro-derived term is accurate and at an appropriate level of specificity for automated annotation.
Supporting Evidence:
PMID:16020546
Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates
|
|
GO:0031966
mitochondrial membrane
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: IEA annotation from ARBA. ACAD9 is localized to the mitochondrial inner membrane. This term is broader (parent) than the more specific mitochondrial inner membrane annotations also present, but is not incorrect.
Reason: ACAD9 is experimentally localized to the mitochondrial membrane (specifically the inner membrane). This broader IEA term is subsumed by more specific annotations but remains valid.
Supporting Evidence:
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
|
|
GO:0050660
flavin adenine dinucleotide binding
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: IEA annotation based on InterPro domain mapping. ACAD9 is a FAD-containing flavoprotein. FAD binding has been experimentally demonstrated, with approximately 70% FAD occupancy in purified protein (PMID:34646991). FAD binding is essential for the dehydrogenase function, and ECSIT binding causes deflavination (PMID:33320993, PMID:38086790).
Reason: ACAD9 binds FAD as a cofactor for its acyl-CoA dehydrogenase activity. The FAD content of purified ACAD9 is approximately 70% (PMID:34646991), and ECSIT-mediated deflavination switches ACAD9 from FAO enzyme to CI assembly factor (PMID:33320993).
Supporting Evidence:
PMID:34646991
the FAD content of purified wild type ACAD9 protein (non-tagged ACAD9 and ACAD9-His6) was approximately 70%
PMID:33320993
interaction with ECSIT induces ACAD9 to eject its FAD cofactor from the catalytic site
|
|
GO:0070991
medium-chain fatty acyl-CoA dehydrogenase activity
|
IEA
GO_REF:0000120 |
KEEP AS NON CORE |
Summary: IEA annotation from ARBA/Rhea mapping based on EC 1.3.8.7. ACAD9 does have some activity toward medium-chain substrates (C9-C11-CoA) as demonstrated in PMID:16020546. However, its primary specificity is for long-chain substrates; medium-chain activity is lower and secondary.
Reason: While ACAD9 is primarily a long-chain ACAD, it does have experimentally demonstrated medium-chain activity (PMID:16020546), and this is consistent with the EC 1.3.8.7 assignment in UniProt. The IEA annotation correctly reflects the catalogued EC number.
Supporting Evidence:
PMID:16020546
Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)
|
|
GO:0017099
very-long-chain fatty acyl-CoA dehydrogenase activity
|
IDA
PMID:33320993 Assembly of The Mitochondrial Complex I Assembly Complex Sug... |
MODIFY |
Summary: IDA annotation from FlyBase based on Giachin et al. 2021, which characterized ACAD9 acyl-CoA dehydrogenase activity using an ETF fluorescence reduction assay with palmitoyl-CoA (C16:0) as substrate. While ACAD9 does have dehydrogenase activity, the term "very-long-chain" (GO:0017099, typically C20+) may be an over-annotation. ACAD9's primary substrates are long-chain (C14-C18), not very-long-chain. The activity measured in this paper used palmitoyl-CoA (C16:0), which is a long-chain substrate.
Reason: ACAD9 has optimal activity with long-chain (C14-C18) substrates, not very-long-chain (C20+). The paper PMID:33320993 demonstrated ACAD dehydrogenase activity using palmitoyl-CoA (C16:0), which is a long-chain substrate. While ACAD9 does have some activity on C20:0 (eicosanoyl-CoA) as shown in PMID:16020546, its primary specificity is long-chain. The annotation should be modified to long-chain fatty acyl-CoA dehydrogenase activity (GO:0004466).
Proposed replacements:
long-chain fatty acyl-CoA dehydrogenase activity
Supporting Evidence:
PMID:33320993
After addition of the ACAD specific substrate palmitoyl-CoA (C16:0), there is a clear loss of ETF fluorescence in ACAD9 alone
PMID:16020546
Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)
|
|
GO:0017099
very-long-chain fatty acyl-CoA dehydrogenase activity
|
IDA
PMID:34646991 Molecular mechanism of interactions between ACAD9 and bindin... |
MODIFY |
Summary: IDA annotation from FlyBase based on Xia et al. 2021 (iScience). This paper characterized ACAD9 enzymatic activity using palmitoyl-CoA (C16:0) as substrate and measured dehydrogenation activity of 83 min-1. The activity is real but the term "very-long-chain" is an overstatement of specificity, since palmitoyl-CoA is a long-chain substrate.
Reason: Same reasoning as above. ACAD9 has its optimal activity on long-chain substrates (C14-C18). The paper PMID:34646991 used palmitoyl-CoA (C16:0) as substrate, which is long-chain. The VLCAD-like annotation is misleading; ACAD9 activity is only 18% of VLCAD activity (PMID:34646991).
Proposed replacements:
long-chain fatty acyl-CoA dehydrogenase activity
Supporting Evidence:
PMID:34646991
this activity is only 18% of VLCAD activity
PMID:34646991
As purified, the wild-type ACAD9 protein has a dehydrogenation activity of 83 min-1, attributable to the FAD-containing holo-form of the protein
|
|
GO:0030674
protein-macromolecule adaptor activity
|
IDA
PMID:32320651 Dissecting the Roles of Mitochondrial Complex I Intermediate... |
ACCEPT |
Summary: IDA annotation from FlyBase based on Formosa et al. 2020, which demonstrated that ACAD9 is a core component of the MCIA complex and acts as an adaptor linking ECSIT (and through it, NDUFAF1) to CI assembly intermediates. The study showed ACAD9 forms a hierarchy of stability centered on itself within the MCIA complex. This is an excellent annotation capturing ACAD9's primary assembly factor role using a molecular function term.
Reason: ACAD9 functions as a protein-macromolecule adaptor within the MCIA complex, bridging ECSIT to CI assembly intermediates. This is well-supported by PMID:32320651, which showed that knockout of ACAD9 destabilizes the entire MCIA complex, and by structural studies showing ACAD9 provides binding surfaces for ECSIT via its vestigial dehydrogenase domain (PMID:33320993, PMID:38086790). This annotation captures the core molecular function of ACAD9 in CI assembly.
Supporting Evidence:
PMID:32320651
while each MCIA component is critical for complex I assembly, a hierarchy of stability exists centered on ACAD9
PMID:33320993
ECSIT functions as the bridging node of the MCIA core complex
|
|
GO:0160295
mitochondrial complex I intermediate assembly complex
|
IDA
PMID:33320993 Assembly of The Mitochondrial Complex I Assembly Complex Sug... |
ACCEPT |
Summary: IDA annotation from FlyBase based on Giachin et al. 2021. This study provided extensive structural and biochemical evidence that ACAD9 is a core component of the MCIA complex, including cryo-EM structures, SAXS, native MS, and SEC-MALLS data demonstrating stable ACAD9-ECSIT complexes.
Reason: ACAD9 is unequivocally a component of the MCIA complex. Giachin et al. demonstrated formation of the ACAD9-ECSIT binary complex by multiple biophysical methods and showed ECSIT binds the vestigial dehydrogenase domain of ACAD9 (PMID:33320993). This is a core annotation for ACAD9.
Supporting Evidence:
PMID:33320993
ECSIT functions as the bridging node of the MCIA core complex
PMID:33320993
the C-terminal domain of ECSIT directly binds to the vestigial dehydrogenase domain of the FAO enzyme ACAD9 and induces its deflavination
|
|
GO:0160295
mitochondrial complex I intermediate assembly complex
|
IDA
PMID:34646991 Molecular mechanism of interactions between ACAD9 and bindin... |
ACCEPT |
Summary: IDA annotation from FlyBase based on Xia et al. 2021 (iScience). This study reconstituted the ACAD9/ECSIT/NDUFAF1 ternary complex in vitro and characterized it by SEC, SAXS, and pull-down assays, demonstrating ACAD9 is a core member of the MCIA complex.
Reason: Xia et al. provided direct biochemical evidence for ACAD9 as part of the MCIA ternary complex with ECSIT and NDUFAF1, including purification of the stable ternary complex with 1:1:1 stoichiometry (PMID:34646991). This is strong supporting evidence for the CC annotation.
Supporting Evidence:
PMID:34646991
ACAD9, ECSIT, and NDUFAF1 form the core mitochondrial CI assembly (MCIA) complex
PMID:34646991
mixing of the three purified, individual proteins forms a ternary complex, ACAD9/ECSIT/NDUFAF1, with a 1:1:1 molar (monomer) ratio
|
|
GO:0005739
mitochondrion
|
IDA
GO_REF:0000052 |
ACCEPT |
Summary: IDA annotation from HPA based on immunofluorescence data. ACAD9 localization to mitochondria is well-established across multiple studies and methods.
Reason: ACAD9 mitochondrial localization is confirmed by multiple independent approaches: submitochondrial fractionation (PMID:16020546), immunofluorescence (PMID:20816094), and proteomics (PMID:34800366). The HPA immunofluorescence data is consistent with this body of evidence.
Supporting Evidence:
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
|
|
GO:0160295
mitochondrial complex I intermediate assembly complex
|
IDA
PMID:32320651 Dissecting the Roles of Mitochondrial Complex I Intermediate... |
ACCEPT |
Summary: IDA annotation from FlyBase based on Formosa et al. 2020. This study used cell knockout studies of each MCIA component and demonstrated that ACAD9 is central to MCIA complex stability, also identifying TMEM186 and COA1 as additional MCIA components.
Reason: Formosa et al. provided strong genetic evidence from knockout studies that ACAD9 is a core component of the MCIA complex, with a central role in maintaining complex stability. Loss of ACAD9 resulted in destabilization of the entire MCIA complex and impaired CI assembly (PMID:32320651).
Supporting Evidence:
PMID:32320651
The mitochondrial complex I intermediate assembly (MCIA) complex, containing assembly factors NDUFAF1, ECSIT, ACAD9, and TMEM126B, is required for building the intermediate ND2-module
PMID:32320651
while each MCIA component is critical for complex I assembly, a hierarchy of stability exists centered on ACAD9
|
|
GO:0003995
acyl-CoA dehydrogenase activity
|
IDA
PMID:38086790 The assembly of the Mitochondrial Complex I Assembly complex... |
ACCEPT |
Summary: IDA annotation from FlyBase based on McGregor et al. 2023 (Nature Communications). This study determined a 3.0 A cryo-EM structure of the ACAD9-ECSIT complex and also characterized ACAD9 dehydrogenase activity using the ETF fluorescence reduction assay with palmitoyl-CoA. The study demonstrated ECSIT binding induces a large conformational change in the FAD-binding loop of ACAD9, releasing FAD and converting ACAD9 from an FAO enzyme to a CI assembly factor.
Reason: McGregor et al. directly measured ACAD9 acyl-CoA dehydrogenase activity via ETF fluorescence reduction assay and confirmed the deflavination mechanism (PMID:38086790). This provides direct experimental evidence for ACAD9's enzymatic function.
Supporting Evidence:
PMID:38086790
ECSIT binding induces a major conformational change in the FAD-binding loop of ACAD9, releasing the FAD cofactor and converting ACAD9 from a fatty acid beta-oxidation (FAO) enzyme to a CI assembly factor
|
|
GO:0005743
mitochondrial inner membrane
|
NAS
PMID:32320651 Dissecting the Roles of Mitochondrial Complex I Intermediate... |
ACCEPT |
Summary: NAS annotation from ComplexPortal based on PMID:32320651. ACAD9 functions as part of the MCIA complex at the mitochondrial inner membrane where CI assembly occurs. This is consistent with the experimentally determined localization.
Reason: ACAD9 is localized to the mitochondrial inner membrane, matrix side, as a peripheral membrane protein. This is well-supported by fractionation studies (PMID:16020546) and is the site of its CI assembly function as part of the MCIA complex (PMID:32320651).
Supporting Evidence:
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
|
|
GO:0032981
mitochondrial respiratory chain complex I assembly
|
NAS
PMID:32320651 Dissecting the Roles of Mitochondrial Complex I Intermediate... |
ACCEPT |
Summary: NAS annotation from ComplexPortal based on Formosa et al. 2020. ACAD9 is essential for CI assembly as a core member of the MCIA complex. This is the primary biological process annotation for ACAD9 and represents its most important physiological function.
Reason: CI assembly is the primary biological process function of ACAD9. Multiple studies demonstrate that loss of ACAD9 causes isolated CI deficiency (PMID:20816094), ACAD9 is part of the MCIA complex required for ND2-module assembly (PMID:32320651), and disease mutations cluster in the assembly domain (PMID:20816094).
Supporting Evidence:
PMID:32320651
The mitochondrial complex I intermediate assembly (MCIA) complex, containing assembly factors NDUFAF1, ECSIT, ACAD9, and TMEM126B, is required for building the intermediate ND2-module
PMID:20816094
ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required for the assembly of complex I
file:human/ACAD9/ACAD9-deep-research-falcon.md
its dominant essential role is as a CI assembly factor within MCIA.
|
|
GO:0005739
mitochondrion
|
HTP
PMID:34800366 Quantitative high-confidence human mitochondrial proteome an... |
ACCEPT |
Summary: HTP annotation from high-throughput human mitochondrial proteome study (Morgenstern et al. 2021). ACAD9 was identified as a high-confidence mitochondrial protein. This is consistent with extensive prior evidence.
Reason: ACAD9 is a well-established mitochondrial protein. Its identification in a quantitative high-confidence mitochondrial proteome study (PMID:34800366) adds further confirmation to established knowledge from targeted studies (PMID:16020546, PMID:20816094).
Supporting Evidence:
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
|
|
GO:0005515
protein binding
|
IPI
PMID:33753518 TMEM70 and TMEM242 help to assemble the rotor ring of human ... |
MARK AS OVER ANNOTATED |
Summary: IPI annotation based on Carroll et al. 2021, which showed TMEM70 and TMEM242 interact with MCIA complex components including ACAD9. The WITH field includes UniProtKB:Q8IUX1 (TMEM242), Q9BQ95 (TMEM126B), Q9BUB7 (TMEM70), and Q9Y375 (NDUFAF1). While the interactions are real and informative, the term 'protein binding' is uninformative. The adaptor activity annotation (GO:0030674) already captures the functionally relevant aspect.
Reason: The protein binding term is uninformative. The ACAD9 interactions with TMEM70 and TMEM242 are real (PMID:33753518), but this function is better captured by the protein-macromolecule adaptor activity annotation (GO:0030674) and the MCIA complex membership (GO:0160295). Generic 'protein binding' does not tell us anything about the actual function of ACAD9.
Supporting Evidence:
PMID:33753518
TMEM70 and TMEM242 interact with the mitochondrial complex I assembly (the MCIA) complex that supports assembly of the membrane arm of complex I
|
|
GO:0005515
protein binding
|
IPI
PMID:32320651 Dissecting the Roles of Mitochondrial Complex I Intermediate... |
MARK AS OVER ANNOTATED |
Summary: IPI annotation based on Formosa et al. 2020. The WITH field includes TMEM126B (Q96B77), ECSIT (Q9BQ95), TMEM186 (Q9GZY4), and NDUFAF1 (Q9Y375). These are the MCIA complex interactions. While real, 'protein binding' is uninformative.
Reason: Same as above. The interactions with MCIA complex components are real and well-characterized (PMID:32320651), but 'protein binding' is uninformative. The adaptor activity (GO:0030674) and MCIA complex membership (GO:0160295) annotations are more informative.
Supporting Evidence:
PMID:32320651
The mitochondrial complex I intermediate assembly (MCIA) complex, containing assembly factors NDUFAF1, ECSIT, ACAD9, and TMEM126B, is required for building the intermediate ND2-module
|
|
GO:0001676
long-chain fatty acid metabolic process
|
IDA
PMID:16020546 Human acyl-CoA dehydrogenase-9 plays a novel role in the mit... |
KEEP AS NON CORE |
Summary: IDA annotation from BHF-UCL based on Ensenauer et al. 2005. ACAD9 participates in long-chain fatty acid beta-oxidation, with maximal activity toward long-chain unsaturated acyl-CoA substrates (C16:1, C18:1, C18:2, C22:6). This is a secondary/moonlighting function but is experimentally well-supported.
Reason: While ACAD9 does participate in long-chain fatty acid metabolism, this represents a secondary/moonlighting function. The primary in vivo role is CI assembly (PMID:20816094). Disease mutations cause CI deficiency rather than primary FAO defects (PMID:20816094). However, FAO activity is tissue-relevant especially in brain where ACAD9 is the main long-chain ACAD (PMID:16020546, PMID:17564966).
Supporting Evidence:
PMID:16020546
Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)
PMID:20816094
ACAD9 mutations result in complex I deficiency and not in disturbed long-chain fatty acid oxidation
|
|
GO:0004466
long-chain fatty acyl-CoA dehydrogenase activity
|
IDA
PMID:16020546 Human acyl-CoA dehydrogenase-9 plays a novel role in the mit... |
ACCEPT |
Summary: IDA annotation from BHF-UCL based on Ensenauer et al. 2005. ACAD9 was purified, expressed, and its substrate utilization pattern characterized, demonstrating maximal activity with long-chain (C16-C18) unsaturated acyl-CoA substrates. This is the most appropriate specific MF term for ACAD9's enzymatic activity.
Reason: ACAD9 has well-characterized long-chain acyl-CoA dehydrogenase activity with Km values of 2.8 uM for hexadecanoyl-CoA and 0.7 uM for (9Z)-hexadecenoyl-CoA (PMID:16020546). This is the correct level of specificity for ACAD9's enzymatic function.
Supporting Evidence:
PMID:16020546
Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)
|
|
GO:0005739
mitochondrion
|
IDA
PMID:16020546 Human acyl-CoA dehydrogenase-9 plays a novel role in the mit... |
ACCEPT |
Summary: IDA annotation from BHF-UCL based on Ensenauer et al. 2005. Submitochondrial fractionation studies confirmed ACAD9 is associated with the mitochondrial membrane.
Reason: Direct experimental evidence from submitochondrial fractionation demonstrates ACAD9 is a mitochondrial protein associated with mitochondrial membranes (PMID:16020546).
Supporting Evidence:
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
|
|
GO:0031966
mitochondrial membrane
|
IDA
PMID:16020546 Human acyl-CoA dehydrogenase-9 plays a novel role in the mit... |
ACCEPT |
Summary: IDA annotation from BHF-UCL based on Ensenauer et al. 2005. Submitochondrial fractionation showed ACAD9 is membrane-associated. This is less specific than the inner membrane annotation but still correct based on the fractionation data.
Reason: ACAD9 is a peripheral membrane protein associated with the mitochondrial inner membrane on the matrix side (PMID:16020546). The mitochondrial membrane annotation is correct, though the more specific inner membrane annotation is also present.
Supporting Evidence:
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
|
|
GO:0051791
medium-chain fatty acid metabolic process
|
IDA
PMID:16020546 Human acyl-CoA dehydrogenase-9 plays a novel role in the mit... |
KEEP AS NON CORE |
Summary: IDA annotation from BHF-UCL based on Ensenauer et al. 2005. ACAD9 shows some activity toward medium-chain substrates (C9-C11-CoA) in addition to its primary long-chain specificity. This is a secondary activity.
Reason: ACAD9 does have some medium-chain acyl-CoA dehydrogenase activity (PMID:16020546), but its primary enzymatic specificity is for long-chain substrates, and its primary biological role is CI assembly. Medium-chain FAO is a minor secondary activity, better handled by MCAD in vivo.
Supporting Evidence:
PMID:16020546
Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)
|
|
GO:0070991
medium-chain fatty acyl-CoA dehydrogenase activity
|
IDA
PMID:16020546 Human acyl-CoA dehydrogenase-9 plays a novel role in the mit... |
KEEP AS NON CORE |
Summary: IDA annotation from BHF-UCL based on Ensenauer et al. 2005. ACAD9 shows activity toward some medium-chain substrates in the C9-C11 range. While less active than on long-chain substrates, this has been directly demonstrated experimentally.
Reason: ACAD9 does have demonstrable medium-chain acyl-CoA dehydrogenase activity (PMID:16020546), though this is secondary to its long-chain specificity and far secondary to its CI assembly role. The activity is real but minor compared to dedicated MCAD.
Supporting Evidence:
PMID:16020546
Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)
|
|
GO:0005743
mitochondrial inner membrane
|
TAS
Reactome:R-HSA-6799179 |
ACCEPT |
Summary: TAS annotation from Reactome pathway "Peripheral arm subunits bind the 815kDa complex to form a 980kDa complex". ACAD9 functions at the mitochondrial inner membrane as part of the MCIA complex during CI biogenesis.
Reason: ACAD9 is localized to the mitochondrial inner membrane where CI assembly takes place. This is well-supported experimentally (PMID:16020546, PMID:20816094) and the Reactome annotation correctly reflects this.
Supporting Evidence:
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
|
|
GO:0005743
mitochondrial inner membrane
|
TAS
Reactome:R-HSA-6799196 |
ACCEPT |
Summary: TAS annotation from Reactome pathway "The MCIA complex, NDUFAF2-7 all dissociate from the 980kDa complex, resulting in Complex I". Consistent with ACAD9's role as an MCIA assembly factor at the inner membrane.
Reason: Same as above. ACAD9 is at the mitochondrial inner membrane and this Reactome step describes MCIA complex dissociation after CI assembly is complete. Well-supported experimentally.
Supporting Evidence:
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
|
|
GO:0005743
mitochondrial inner membrane
|
TAS
Reactome:R-HSA-6799197 |
ACCEPT |
Summary: TAS annotation from Reactome pathway "ND4, ND5 bind the 550kDa complex to form the 815kDa complex". Another step in CI biogenesis at the inner membrane.
Reason: Consistent with ACAD9's role as an MCIA assembly factor at the mitochondrial inner membrane.
Supporting Evidence:
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
|
|
GO:0005743
mitochondrial inner membrane
|
TAS
Reactome:R-HSA-6799199 |
ACCEPT |
Summary: TAS annotation from Reactome pathway "COA1:MT-ND2, TMEM186:MT-ND3, MT-ND6, NDUFB6 bind the MCIA complex to form a 370kDa subcomplex". This step directly involves the MCIA complex of which ACAD9 is a core member.
Reason: ACAD9 is a core member of the MCIA complex that participates in this assembly step. Well-supported by PMID:32320651.
Supporting Evidence:
PMID:32320651
The mitochondrial complex I intermediate assembly (MCIA) complex, containing assembly factors NDUFAF1, ECSIT, ACAD9, and TMEM126B, is required for building the intermediate ND2-module
|
|
GO:0005743
mitochondrial inner membrane
|
TAS
Reactome:R-HSA-6799202 |
ACCEPT |
Summary: TAS annotation from Reactome pathway "The 315kDa subcomplex binds the 370kDa subcomplex to form the 550kDa complex". Another CI assembly step at the inner membrane.
Reason: Consistent with ACAD9's role as an MCIA assembly factor at the mitochondrial inner membrane.
Supporting Evidence:
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
|
|
GO:0005515
protein binding
|
IPI
PMID:20816094 Acyl-CoA dehydrogenase 9 is required for the biogenesis of o... |
MARK AS OVER ANNOTATED |
Summary: IPI annotation based on Nouws et al. 2010, which showed ACAD9 interacts with NDUFAF1 (Q9Y375) and ECSIT (Q9BQ95). These are the foundational interactions establishing ACAD9 as an MCIA complex member. However, 'protein binding' is uninformative.
Reason: The interactions demonstrated by Nouws et al. (PMID:20816094) are central to understanding ACAD9's CI assembly function, but the generic 'protein binding' term fails to capture the biological significance. The adaptor activity (GO:0030674) and MCIA complex membership (GO:0160295) annotations are far more informative.
Supporting Evidence:
PMID:20816094
ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required for the assembly of complex I
|
|
GO:0005739
mitochondrion
|
IDA
PMID:20816094 Acyl-CoA dehydrogenase 9 is required for the biogenesis of o... |
ACCEPT |
Summary: IDA annotation based on Nouws et al. 2010. ACAD9 was shown to localize to mitochondria as part of the study establishing its role in CI assembly.
Reason: ACAD9 mitochondrial localization is well-established and confirmed in this study (PMID:20816094) which demonstrated ACAD9 interactions with mitochondrial CI assembly factors.
Supporting Evidence:
PMID:20816094
ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required for the assembly of complex I
|
|
GO:0032981
mitochondrial respiratory chain complex I assembly
|
IMP
PMID:20816094 Acyl-CoA dehydrogenase 9 is required for the biogenesis of o... |
ACCEPT |
Summary: IMP annotation based on Nouws et al. 2010. This landmark study demonstrated that ACAD9 mutations result in CI deficiency (not FAO deficiency), establishing CI assembly as ACAD9's primary function. ACAD9 knockdown/mutation leads to impaired CI assembly. This is the strongest evidence for ACAD9's primary biological process.
Reason: Nouws et al. provided the foundational evidence that ACAD9 is required for CI biogenesis, showing that ACAD9 mutations cause CI deficiency rather than FAO defects, and that ACAD9 interacts with known CI assembly factors NDUFAF1 and ECSIT (PMID:20816094). This IMP annotation is the most critical biological process annotation for ACAD9.
Supporting Evidence:
PMID:20816094
ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required for the assembly of complex I
PMID:20816094
ACAD9 mutations result in complex I deficiency and not in disturbed long-chain fatty acid oxidation
|
|
GO:0005634
nucleus
|
IDA
PMID:21237683 Identification and characterization of new long chain acyl-C... |
REMOVE |
Summary: IDA annotation based on He et al. 2011. This study characterized new long-chain ACADs including ACAD9, ACAD10, and ACAD11, and reported ACAD9 in the nucleus. However, ACAD9 is a mitochondrial protein with a mitochondrial transit peptide, and all functional studies place it in mitochondria. Nuclear localization is likely an artifact of overexpression or immunostaining cross-reactivity and is not supported by the consensus of literature.
Reason: ACAD9 has a mitochondrial transit peptide (residues 1-37, cleaved upon import; PMID:16020546) and all functional characterization places it in mitochondria. The nuclear localization reported in PMID:21237683 is not supported by other studies and is likely artifactual. UniProt does not include nuclear localization. The extensive proteomics and fractionation data consistently place ACAD9 in mitochondria only.
Supporting Evidence:
PMID:16020546
A 37-amino acid leader peptide was cleaved sequentially by two mitochondrial peptidases to yield a predicted molecular mass of 65 kDa for the mature subunit
|
|
GO:0030425
dendrite
|
IDA
PMID:21237683 Identification and characterization of new long chain acyl-C... |
REMOVE |
Summary: IDA annotation based on He et al. 2011. The study examined ACAD expression patterns in human cerebellum and found ACAD9 was highly expressed in the granular layer. The dendrite annotation likely reflects immunohistochemical staining of neuronal processes. However, this is a cell-type expression pattern rather than a specific subcellular localization to dendrites. The protein within those cells is still in mitochondria.
Reason: ACAD9 is a mitochondrial matrix-facing protein. Finding it in neurons (including dendritic processes) reflects tissue expression (ACAD9 is highly expressed in cerebellum) rather than specific dendritic localization. The protein is in mitochondria within dendrites, not in the dendritic cytoplasm. This annotation conflates cell-type expression with subcellular localization.
Supporting Evidence:
PMID:21237683
ACAD9 was most highly expressed in the granular layer
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
|
|
GO:0005739
mitochondrion
|
IDA
GO_REF:0000054 |
ACCEPT |
Summary: IDA annotation from LIFEdb based on expressed fusion protein localization in living cells. ACAD9 localization to mitochondria was confirmed, consistent with all other evidence.
Reason: ACAD9 mitochondrial localization is well-established. The LIFEdb fusion protein experiment confirms what is known from multiple other approaches (PMID:16020546, PMID:20816094, PMID:34800366).
Supporting Evidence:
PMID:16020546
Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane
|
|
GO:0006635
fatty acid beta-oxidation
|
IDA
PMID:16020546 Human acyl-CoA dehydrogenase-9 plays a novel role in the mit... |
NEW |
Summary: ACAD9 catalyzes the first step of mitochondrial fatty acid beta-oxidation, the alpha,beta-dehydrogenation of long-chain fatty acyl-CoA substrates. This specific biological process term is not currently annotated but is more precise than the existing GO:0006631 (fatty acid metabolic process) and GO:0001676 (long-chain fatty acid metabolic process) annotations.
Reason: ACAD9 directly catalyzes the first step of the beta-oxidation cycle. The existing BP annotations (GO:0006631 fatty acid metabolic process, GO:0001676 long-chain fatty acid metabolic process) are correct but the more specific fatty acid beta-oxidation term is warranted given the direct experimental evidence. This is ACAD9's secondary core function.
Supporting Evidence:
PMID:16020546
Human acyl-CoA dehydrogenase-9 plays a novel role in the mitochondrial beta-oxidation of unsaturated fatty acids
PMID:34646991
ACAD9 was first identified as a member of the acyl-CoA dehydrogenase family catalyzing the alpha, beta-dehydrogenation of fatty acyl-CoA thioesters, the first step of the fatty acid beta-oxidation cycle
|
Q: What is the relative abundance of ACAD9 in its FAO (holo, FAD-bound) vs. CI assembly (apo, ECSIT-bound) states in different human tissues? Current understanding is based primarily on in vitro reconstitution, and the relative partitioning between FAO and assembly functions in vivo remains poorly quantified.
Q: Is there evidence that ACAD9 FAO function contributes to disease severity in ACAD9 deficiency, beyond the CI assembly defect? Schiff et al. 2015 suggested both CI assembly and FAO enzyme activity contribute to disease severity, but the relative contribution remains debated.
Experiment: Quantitative proteomics to measure the fraction of ACAD9 in ECSIT-bound (assembly) vs. free (FAO-competent) states across human tissues, especially brain regions. This would clarify the in vivo partitioning of ACAD9 between its two mutually exclusive functions.
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Research plan and verification steps
- We verified the target: ACAD9 (HGNC:21497), UniProt Q9H845, a human mitochondrial acyl‑CoA dehydrogenase–family protein that functions as an essential Complex I (CI) assembly factor. Literature consistently identifies ACAD9 as a FAD‑binding homodimer paralogous to VLCAD that participates in CI biogenesis via the MCIA complex, confirming alignment with the UniProt description, domains, and family membership. No conflicting gene symbol usage was encountered in other organisms within the cited literature (all human-focused) (xia2021molecularmechanismof pages 1-2, xia2021molecularmechanismof pages 14-16, xia2021molecularmechanismof pages 2-4, mcgregor2023theassemblyof pages 1-2, nouws2013humanmitochondrialcomplex pages 70-73).
Comprehensive research report
1) Key concepts and definitions (current understanding)
- Identity and dual function: ACAD9 is a FAD‑dependent acyl‑CoA dehydrogenase paralog that also serves as an essential assembly factor for mitochondrial Complex I (CI). As an enzyme, ACAD9 catalyzes the α,β‑dehydrogenation step of long‑chain fatty acyl‑CoA in fatty‑acid β‑oxidation (FAO). As an assembly factor, ACAD9 is a core member of the Mitochondrial Complex I Assembly (MCIA) complex, partnering with ECSIT and NDUFAF1 to build the ND2 membrane‑arm module of CI (functions are mutually exclusive; see below) (xia2021molecularmechanismof pages 1-2, xia2021molecularmechanismof pages 14-16, xia2021molecularmechanismof pages 2-4, mcgregor2023theassemblyof pages 1-2).
- Primary role in vivo: Multiple genetic and cell‑biological studies indicate that ACAD9’s predominant physiological role is in CI biogenesis, with knockdown or mutation producing isolated CI deficiency and accumulation of defined assembly intermediates (nouws2013humanmitochondrialcomplex pages 70-73, schiff2015complexiassembly pages 1-2).
2) Molecular function and enzymatic activity (substrate specificity) versus assembly role
- Enzymatic activity: Purified human ACAD9 forms a FAD‑containing homodimer with measurable dehydrogenation activity toward long‑chain acyl‑CoA substrates; its catalytic rate is lower than VLCAD (~20% of VLCAD under comparable conditions). FAD binding stabilizes the ACAD9 dimer; the catalytic glutamate (E426) is essential for activity. ACAD9 exhibits sub‑stoichiometric FAD occupancy in vitro (~70%), and activity can be increased by adding FAD, reflecting relatively weak FAD binding in the apo state (xia2021molecularmechanismof pages 2-4, xia2021molecularmechanismof pages 13-14, xia2021molecularmechanismof pages 1-2).
- Assembly role via MCIA: ACAD9 forms the core MCIA ternary complex by binding ECSIT (ACAD9 N‑terminal domain to ECSIT C‑terminal domain) and NDUFAF1 (to ECSIT N‑terminal domain). This ternary complex is stable and required for assembly of ND2‑module intermediates of CI; loss of MCIA components causes specific CI assembly failure (xia2021molecularmechanismof pages 1-2, xia2021molecularmechanismof pages 14-16).
- Functional exclusivity and switching: Binding of ECSIT to ACAD9 triggers “deflavination” (loss of the FAD cofactor) and abrogates dehydrogenase activity, thereby switching ACAD9 from an FAO enzyme to a CI assembly factor. ECSIT and ETF (electron transfer flavoprotein) compete for overlapping sites on ACAD9’s N‑terminal region near FAD, mechanistically enforcing mutual exclusivity between FAO (ETF‑bound, FAD‑loaded) and assembly (ECSIT‑bound, deflavinated) states (xia2021molecularmechanismof pages 1-2, xia2021molecularmechanismof pages 14-16, xia2021molecularmechanismof pages 13-14, giachin2021assemblyofthe pages 3-4).
3) Subcellular localization, interacting partners, and structural mechanisms
- Localization: ACAD9 is a mitochondrial matrix‑facing homodimer associated with the inner membrane where CI is assembled (nouws2013humanmitochondrialcomplex pages 70-73).
- Interacting partners: Core MCIA partners include ECSIT and NDUFAF1; the MCIA functional module cooperates with TMEM126B/TMEM186 in ND2‑arm assembly. ETF interacts with ACAD9 in its enzymatic (FAO) state but is excluded by ECSIT during assembly (xia2021molecularmechanismof pages 2-4, xia2021molecularmechanismof pages 1-2, xia2021molecularmechanismof pages 14-16, xia2021molecularmechanismof pages 13-14).
- Structural mechanism (deflavination): High‑resolution structural and biophysical work demonstrates that a C‑terminal ECSIT fragment binds ACAD9 and induces a conformational change in the FAD‑binding loop, causing FAD release (“deflavination”). Key interfacial residues include a salt bridge (ECSIT Glu323–ACAD9 Lys228) and a hydrogen bond (ECSIT Trp324–ACAD9 Ser191). ECSIT phosphorylation reduces ACAD9 binding; exposure of neuronal cells to amyloid‑β oligomers lowers ECSIT phosphorylation and promotes ECSIT–ACAD9 association, linking MCIA regulation to neurodegenerative stress (mcgregor2023theassemblyof pages 1-2, giachin2021assemblyofthe pages 3-4).
4) Disease associations and phenotypes
- Isolated Complex I deficiency: ACAD9 mutations produce isolated CI deficiency with phenotypes ranging from severe neonatal disease (metabolic acidosis, Leigh syndrome, hypertrophic cardiomyopathy) to later‑onset myopathy and multisystem involvement. Early multicenter cohorts demonstrated that ACAD9 loss compromises CI assembly and activity in patient cells and tissues (schiff2015complexiassembly pages 1-2, nouws2013humanmitochondrialcomplex pages 70-73).
- Clinical spectrum and severity: A large compiled cohort of 70 ACAD9‑deficient patients reported high early mortality (>50% within the first year) among severe infantile cases; individuals with onset after 1 year of age had markedly better survival (>80%), often with riboflavin responsiveness (see below) (murgia2023newinsightsinto pages 9-11).
- Contribution of FAO impairment: Functional analyses of 16 ACAD9 variants from 24 patients support that both CI assembly failure and partial loss of ACAD enzymatic function correlate with disease severity; tissues with high ACAD9 expression (e.g., liver, neurons) may be more sensitive to its FAO role, complementing its obligatory assembly function (schiff2015complexiassembly pages 1-2).
5) Riboflavin (vitamin B2) responsiveness and therapeutic rationale
- Mechanistic rationale: As a FAD precursor, riboflavin may act as a chemical chaperone by improving FAD loading, folding, and stability of mutant ACAD9, partially restoring function. In vitro, excess FAD can restore dehydrogenase activity to ACAD9/ECSIT complexes, consistent with this model (xia2021molecularmechanismof pages 13-14).
- Clinical evidence: Cohort‑level data indicate that later‑onset ACAD9 deficiency often responds to riboflavin with improved outcomes, while severe neonatal cases show limited benefit. Individual patient fibroblast studies document increased CI activity (e.g., 1.7–2.1×) after riboflavin exposure, though not all genotypes respond (e.g., variants near the FAD pocket showed poor response in one case), underscoring genotype‑specific effects and the need for clinical monitoring (murgia2023newinsightsinto pages 9-11, nouws2013humanmitochondrialcomplex pages 117-118).
6) Recent developments (prioritized 2023–2024)
- Structural basis of the switch to assembly: Nature Communications (2023) defined the ECSIT–ACAD9 interface that enforces deflavination and the functional switch to CI assembly; it also linked ECSIT phosphorylation dynamics to amyloid‑β exposure in neurons, suggesting stress‑regulated control of MCIA (mcgregor2023theassemblyof pages 1-2).
- Ongoing refinement of MCIA mechanisms: Contemporary structural/biophysical paradigms from 2021–2023 consolidate that MCIA relies on ECSIT as a bridging hub that binds ACAD9 C‑terminally and NDUFAF1 N‑terminally, rendering a stable complex that coordinates formation of ND2‑module intermediates and underscores the biochemical exclusivity between FAO and assembly states (xia2021molecularmechanismof pages 1-2, xia2021molecularmechanismof pages 14-16, giachin2021assemblyofthe pages 3-4, mcgregor2023theassemblyof pages 1-2).
- Translational perspective: A 2023 nutrition‑genomics review synthesizes cohort data on riboflavin‑responsive flavoprotein disorders including ACAD9, highlighting survival statistics, genotypic nuances, and proposing personalized riboflavin therapy frameworks for late‑onset cases (murgia2023newinsightsinto pages 9-11).
7) Current applications and real‑world implementations
- Diagnostics: Next‑generation sequencing for suspected mitochondrial disease frequently identifies ACAD9 variants; functional confirmation includes BN‑PAGE/enzymology for CI deficiency and, when feasible, FAO flux testing in tissues with higher ACAD9 expression. The dual role cautions that skin fibroblasts (low ACAD9) may under‑detect FAO defects, whereas HEK293 and high‑expression tissues better reveal enzymatic contributions (schiff2015complexiassembly pages 1-2, nouws2013humanmitochondrialcomplex pages 70-73).
- Therapeutic approaches: Riboflavin supplementation is commonly attempted given its safety and potential benefit; responses should be tracked clinically and biochemically (e.g., lactate, exercise tolerance, CI activity), recognizing variability by genotype and age of onset (murgia2023newinsightsinto pages 9-11, nouws2013humanmitochondrialcomplex pages 117-118).
8) Expert opinions and authoritative analyses
- Mechanistic consensus: ACAD9 is now broadly regarded as a moonlighting protein whose enzymatic FAO capacity is vestigial relative to VLCAD yet physiologically relevant in select tissues; its dominant essential role is as a CI assembly factor within MCIA. Deflavination triggered by ECSIT is the key structural‑biochemical switch between these roles (xia2021molecularmechanismof pages 1-2, xia2021molecularmechanismof pages 14-16, giachin2021assemblyofthe pages 3-4, mcgregor2023theassemblyof pages 1-2, nouws2013humanmitochondrialcomplex pages 70-73).
- Clinical consensus: ACAD9 deficiency is a leading cause of nuclear‑encoded isolated CI deficiency, with cardiomyopathy common; riboflavin responsiveness is documented in many late‑onset cases though not uniform, and cohort data motivate genotype‑informed, monitored trials (murgia2023newinsightsinto pages 9-11, nouws2013humanmitochondrialcomplex pages 117-118, schiff2015complexiassembly pages 1-2).
9) Quantitative statistics and selected data
- Enzyme biochemistry: Purified ACAD9 dimer shows ~70% FAD occupancy; catalytic activity increases with exogenous FAD (half‑maximal stimulation ~0.75 mM FAD). Mutating the catalytic E426 abolishes activity, confirming canonical ACAD chemistry (xia2021molecularmechanismof pages 2-4).
- Assembly biochemistry: ECSIT binding to ACAD9 causes loss of FAD and dehydrogenase activity; ETF and ECSIT compete for overlapping binding surfaces near the N‑terminal/FAD region (xia2021molecularmechanismof pages 1-2, xia2021molecularmechanismof pages 14-16).
- Clinical cohorts: In a compiled 70‑patient ACAD9 cohort, >50% infant mortality within the first year in severe early‑onset disease; survival >80% in those with onset after 1 year, many of whom received riboflavin (murgia2023newinsightsinto pages 9-11).
- Functional variant testing: Across 16 ACAD9 variants from 24 patients, residual enzymatic activity inversely correlated with clinical severity, supporting a contributory FAO component in disease alongside the required CI assembly function (schiff2015complexiassembly pages 1-2).
10) Pathway placement and cellular site of action
- ACAD9’s assembly function operates at the matrix side of the inner mitochondrial membrane within the MCIA complex to guide ND2‑module formation and integration into CI. Its FAO enzyme function, when engaged, participates in mitochondrial long‑chain fatty‑acid β‑oxidation, transferring electrons to ETF; these two states are structurally incompatible due to ECSIT‑mediated deflavination and ETF competition (nouws2013humanmitochondrialcomplex pages 70-73, xia2021molecularmechanismof pages 1-2, xia2021molecularmechanismof pages 14-16).
References with URLs and publication dates
- McGregor L, et al. The assembly of the Mitochondrial Complex I Assembly complex uncovers a redox pathway coordination. Nature Communications. 2023-12. https://doi.org/10.1038/s41467-023-43865-0 (mcgregor2023theassemblyof pages 1-2)
- Xia C, et al. Molecular mechanism of interactions between ACAD9 and binding partners in mitochondrial respiratory complex I assembly. iScience. 2021-10. https://doi.org/10.1016/j.isci.2021.103153 (xia2021molecularmechanismof pages 1-2, xia2021molecularmechanismof pages 14-16, xia2021molecularmechanismof pages 13-14, xia2021molecularmechanismof pages 2-4)
- Giachin G, et al. Assembly of The Mitochondrial Complex I Assembly Complex Suggests a Regulatory Role for Deflavination. Angew Chem Int Ed. 2021-01. https://doi.org/10.1002/anie.202011548 (giachin2021assemblyofthe pages 3-4)
- Nouws J. Human mitochondrial complex I biogenesis: connections between mitochondrial translation, fatty acid oxidation and complex I assembly. Thesis/monograph. 2013. (contains experimental summaries cited above) (nouws2013humanmitochondrialcomplex pages 70-73, nouws2013humanmitochondrialcomplex pages 117-118)
- Schiff M, et al. Complex I assembly function and fatty acid oxidation enzyme activity of ACAD9 both contribute to disease severity in ACAD9 deficiency. Hum Mol Genet. 2015-06. https://doi.org/10.1093/hmg/ddv074 (schiff2015complexiassembly pages 1-2)
- Murgia C, Dehlia A, Guthridge MA. New insights into the nutritional genomics of adult‑onset riboflavin‑responsive diseases. Nutr Metab (Lond). 2023-10. https://doi.org/10.1186/s12986-023-00764-x (murgia2023newinsightsinto pages 9-11)
Methodological notes and limitations
- While 2023–2024 sources substantially refine ACAD9’s structural switching and regulatory context (deflavination; ECSIT phosphorylation), large controlled treatment trials for riboflavin in ACAD9 deficiency remain limited. Reported cohort statistics come from compiled retrospective cohorts and reviews; genotype‑specific responsiveness should be interpreted cautiously and validated case‑by‑case (mcgregor2023theassemblyof pages 1-2, murgia2023newinsightsinto pages 9-11, nouws2013humanmitochondrialcomplex pages 117-118).
References
(xia2021molecularmechanismof pages 1-2): Chuanwu Xia, Baoying Lou, Zhuji Fu, Al-Walid Mohsen, Anna L. Shen, Jerry Vockley, and Jung-Ja P. Kim. Molecular mechanism of interactions between acad9 and binding partners in mitochondrial respiratory complex i assembly. iScience, 24:103153, Oct 2021. URL: https://doi.org/10.1016/j.isci.2021.103153, doi:10.1016/j.isci.2021.103153. This article has 25 citations and is from a peer-reviewed journal.
(xia2021molecularmechanismof pages 14-16): Chuanwu Xia, Baoying Lou, Zhuji Fu, Al-Walid Mohsen, Anna L. Shen, Jerry Vockley, and Jung-Ja P. Kim. Molecular mechanism of interactions between acad9 and binding partners in mitochondrial respiratory complex i assembly. iScience, 24:103153, Oct 2021. URL: https://doi.org/10.1016/j.isci.2021.103153, doi:10.1016/j.isci.2021.103153. This article has 25 citations and is from a peer-reviewed journal.
(xia2021molecularmechanismof pages 2-4): Chuanwu Xia, Baoying Lou, Zhuji Fu, Al-Walid Mohsen, Anna L. Shen, Jerry Vockley, and Jung-Ja P. Kim. Molecular mechanism of interactions between acad9 and binding partners in mitochondrial respiratory complex i assembly. iScience, 24:103153, Oct 2021. URL: https://doi.org/10.1016/j.isci.2021.103153, doi:10.1016/j.isci.2021.103153. This article has 25 citations and is from a peer-reviewed journal.
(mcgregor2023theassemblyof pages 1-2): Lindsay McGregor, Samira Acajjaoui, Ambroise Desfosses, Melissa Saïdi, Maria Bacia-Verloop, Jennifer J. Schwarz, Pauline Juyoux, Jill von Velsen, Matthew W. Bowler, Andrew A. McCarthy, Eaazhisai Kandiah, Irina Gutsche, and Montserrat Soler-Lopez. The assembly of the mitochondrial complex i assembly complex uncovers a redox pathway coordination. Nature Communications, Dec 2023. URL: https://doi.org/10.1038/s41467-023-43865-0, doi:10.1038/s41467-023-43865-0. This article has 31 citations and is from a highest quality peer-reviewed journal.
(nouws2013humanmitochondrialcomplex pages 70-73): J Nouws. Human mitochondrial complex i biogenesis. connections between mitochondrial translation, fatty acid oxidation and complex i assembly. Unknown journal, 2013.
(schiff2015complexiassembly pages 1-2): Manuel Schiff, Birgit Haberberger, Chuanwu Xia, Al-Walid Mohsen, Eric S Goetzman, Yudong Wang, Radha Uppala, Yuxun Zhang, Anuradha Karunanidhi, Dolly Prabhu, Hana Alharbi, Edward V Prochownik, Tobias Haack, Johannes Häberle, Arnold Munnich, Agnes Rötig, Robert W Taylor, Robert D Nicholls, Jung-Ja Kim, Holger Prokisch, and Jerry Vockley. Complex i assembly function and fatty acid oxidation enzyme activity of acad9 both contribute to disease severity in acad9 deficiency. Human molecular genetics, 24 11:3238-47, Jun 2015. URL: https://doi.org/10.1093/hmg/ddv074, doi:10.1093/hmg/ddv074. This article has 78 citations and is from a domain leading peer-reviewed journal.
(xia2021molecularmechanismof pages 13-14): Chuanwu Xia, Baoying Lou, Zhuji Fu, Al-Walid Mohsen, Anna L. Shen, Jerry Vockley, and Jung-Ja P. Kim. Molecular mechanism of interactions between acad9 and binding partners in mitochondrial respiratory complex i assembly. iScience, 24:103153, Oct 2021. URL: https://doi.org/10.1016/j.isci.2021.103153, doi:10.1016/j.isci.2021.103153. This article has 25 citations and is from a peer-reviewed journal.
(giachin2021assemblyofthe pages 3-4): Gabriele Giachin, Matthew Jessop, Romain Bouverot, Samira Acajjaoui, Melissa Saïdi, Anaïs Chretien, Maria Bacia‐Verloop, Luca Signor, Philippe J. Mas, Adrien Favier, Eve Borel Meneroud, Michael Hons, Darren J. Hart, Eaazhisai Kandiah, Elisabetta Boeri Erba, Alain Buisson, Gordon Leonard, Irina Gutsche, and Montserrat Soler‐Lopez. Assembly of the mitochondrial complex i assembly complex suggests a regulatory role for deflavination. Angewandte Chemie International Edition, 60:4689-4697, Jan 2021. URL: https://doi.org/10.1002/anie.202011548, doi:10.1002/anie.202011548. This article has 28 citations.
(murgia2023newinsightsinto pages 9-11): Chiara Murgia, Ankush Dehlia, and Mark A. Guthridge. New insights into the nutritional genomics of adult-onset riboflavin-responsive diseases. Nutrition & Metabolism, Oct 2023. URL: https://doi.org/10.1186/s12986-023-00764-x, doi:10.1186/s12986-023-00764-x. This article has 17 citations and is from a peer-reviewed journal.
(nouws2013humanmitochondrialcomplex pages 117-118): J Nouws. Human mitochondrial complex i biogenesis. connections between mitochondrial translation, fatty acid oxidation and complex i assembly. Unknown journal, 2013.
id: Q9H845
gene_symbol: ACAD9
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
ACAD9 (Complex I assembly factor ACAD9, mitochondrial) is a dual-function protein that
serves as both a mitochondrial respiratory chain Complex I (CI) assembly factor and an
acyl-CoA dehydrogenase enzyme. Its primary physiological role is as a core component of
the mitochondrial complex I intermediate assembly (MCIA) complex, where it partners with
ECSIT and NDUFAF1 to mediate assembly of the ND2 membrane-arm module of CI. ECSIT binding
triggers a conformational change and deflavination of ACAD9, switching it from an FAO enzyme
to a CI assembly factor. As a secondary/moonlighting function, ACAD9 retains FAD-dependent
acyl-CoA dehydrogenase activity toward long-chain (and some medium-chain) fatty acyl-CoA
substrates (EC 1.3.8.7, 1.3.8.8), catalyzing the first step of mitochondrial fatty acid
beta-oxidation. Disease-causing mutations in ACAD9 result in isolated CI deficiency (MC1DN20),
not primary fatty acid oxidation defects, underscoring the primacy of its assembly role.
ACAD9 is a homodimer localized to the matrix side of the mitochondrial inner membrane.
existing_annotations:
# --- Annotation 1: acyl-CoA dehydrogenase activity (IBA) ---
- term:
id: GO:0003995
label: acyl-CoA dehydrogenase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
ACAD9 is a bona fide acyl-CoA dehydrogenase, belonging to the ACAD family and retaining
catalytic activity for the alpha,beta-dehydrogenation of fatty acyl-CoA substrates. The IBA
annotation is phylogenetically inferred and well-supported by direct biochemical data from
multiple publications (PMID:16020546, PMID:34646991, PMID:38086790). This is an appropriate
level of specificity for the IBA evidence code.
action: ACCEPT
reason: >-
ACAD9 has experimentally demonstrated acyl-CoA dehydrogenase activity. Purified ACAD9 shows
dehydrogenation activity of 83 min-1 with palmitoyl-CoA as substrate (PMID:34646991). The
IBA annotation at the general acyl-CoA dehydrogenase level is appropriate given phylogenetic
support across the ACAD family.
supported_by:
- reference_id: PMID:34646991
supporting_text: "As purified, the wild-type ACAD9 protein has a dehydrogenation activity of 83 min-1, attributable to the FAD-containing holo-form of the protein"
- reference_id: PMID:16020546
supporting_text: "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)"
# --- Annotation 2: acyl-CoA dehydrogenase activity (IEA, InterPro) ---
- term:
id: GO:0003995
label: acyl-CoA dehydrogenase activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: >-
IEA annotation based on InterPro domain mapping. ACAD9 contains the acyl-CoA dehydrogenase
active site signature (IPR006089) which correctly predicts this enzymatic activity. Consistent
with direct experimental evidence.
action: ACCEPT
reason: >-
The InterPro-based IEA annotation is correct and consistent with experimental data showing
ACAD9 possesses acyl-CoA dehydrogenase activity (PMID:16020546, PMID:34646991). This is
a broader annotation that is subsumed by the IBA and IDA annotations but not incorrect.
supported_by:
- reference_id: PMID:16020546
supporting_text: "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates"
# --- Annotation 3: long-chain fatty acyl-CoA dehydrogenase activity (IEA, ARBA) ---
- term:
id: GO:0004466
label: long-chain fatty acyl-CoA dehydrogenase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
IEA annotation from ARBA/Rhea mapping based on the EC 1.3.8.8 catalytic activity. ACAD9
does have demonstrated long-chain acyl-CoA dehydrogenase activity (PMID:16020546), making
this a valid annotation.
action: ACCEPT
reason: >-
ACAD9 has experimentally demonstrated long-chain fatty acyl-CoA dehydrogenase activity
with substrate preference for C16-C22 chain lengths (PMID:16020546). The IEA annotation
correctly captures this function and is consistent with the IDA annotation from BHF-UCL.
supported_by:
- reference_id: PMID:16020546
supporting_text: "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)"
# --- Annotation 4: mitochondrial inner membrane (IEA, SubCell) ---
- term:
id: GO:0005743
label: mitochondrial inner membrane
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: >-
IEA annotation based on UniProtKB/Swiss-Prot subcellular location mapping. ACAD9 is
experimentally localized to the mitochondrial inner membrane, matrix side, as a peripheral
membrane protein (PMID:16020546, PMID:20816094).
action: ACCEPT
reason: >-
Multiple experimental studies confirm ACAD9 localizes to the mitochondrial inner membrane.
Submitochondrial fractionation showed ACAD9 is membrane-associated (PMID:16020546). The
UniProt entry explicitly states "Mitochondrion inner membrane; Peripheral membrane protein;
Matrix side" with evidence from PMID:16020546 and PMID:20816094.
supported_by:
- reference_id: PMID:16020546
supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"
# --- Annotation 5: fatty acid metabolic process (IEA, ARBA) ---
- term:
id: GO:0006631
label: fatty acid metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: >-
IEA annotation from ARBA. ACAD9 participates in fatty acid beta-oxidation by catalyzing
the first step of the FAO cycle. This is a broad term and while accurate, more specific
terms (long-chain fatty acid metabolic process, GO:0001676) are already annotated.
action: ACCEPT
reason: >-
ACAD9 does participate in fatty acid metabolism through its acyl-CoA dehydrogenase activity.
While this IEA term is broader than the IDA annotation to GO:0001676, it is not incorrect
and is an expected consequence of the ARBA mapping.
supported_by:
- reference_id: PMID:16020546
supporting_text: "Human acyl-CoA dehydrogenase-9 plays a novel role in the mitochondrial beta-oxidation of unsaturated fatty acids"
# --- Annotation 6: oxidoreductase activity (IEA, KW) ---
- term:
id: GO:0016491
label: oxidoreductase activity
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >-
IEA annotation based on UniProtKB keyword mapping (KW-0560, Oxidoreductase). ACAD9 is
indeed an oxidoreductase. This is a very general term but is not incorrect for an IEA.
action: ACCEPT
reason: >-
ACAD9 is an oxidoreductase (acyl-CoA dehydrogenase, EC 1.3.8.7/1.3.8.8). While this
is a very broad parent term, it is correctly applied via keyword mapping and more specific
child terms are also annotated.
supported_by:
- reference_id: PMID:16020546
supporting_text: "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates"
# --- Annotation 7: oxidoreductase activity, acting on the CH-CH group of donors (IEA, InterPro) ---
- term:
id: GO:0016627
label: oxidoreductase activity, acting on the CH-CH group of donors
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: >-
IEA annotation based on InterPro domain mapping. ACAD9 catalyzes alpha,beta-dehydrogenation
of fatty acyl-CoA, which is an oxidoreductase reaction acting on CH-CH groups. This is a
correct intermediate-level term between general oxidoreductase and specific acyl-CoA
dehydrogenase activity.
action: ACCEPT
reason: >-
The acyl-CoA dehydrogenase reaction catalyzed by ACAD9 involves oxidation of the CH-CH
bond at the alpha-beta position of fatty acyl-CoA substrates. This InterPro-derived term
is accurate and at an appropriate level of specificity for automated annotation.
supported_by:
- reference_id: PMID:16020546
supporting_text: "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates"
# --- Annotation 8: mitochondrial membrane (IEA, ARBA) ---
- term:
id: GO:0031966
label: mitochondrial membrane
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: >-
IEA annotation from ARBA. ACAD9 is localized to the mitochondrial inner membrane. This
term is broader (parent) than the more specific mitochondrial inner membrane annotations
also present, but is not incorrect.
action: ACCEPT
reason: >-
ACAD9 is experimentally localized to the mitochondrial membrane (specifically the inner
membrane). This broader IEA term is subsumed by more specific annotations but remains valid.
supported_by:
- reference_id: PMID:16020546
supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"
# --- Annotation 9: flavin adenine dinucleotide binding (IEA, InterPro) ---
- term:
id: GO:0050660
label: flavin adenine dinucleotide binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: >-
IEA annotation based on InterPro domain mapping. ACAD9 is a FAD-containing flavoprotein.
FAD binding has been experimentally demonstrated, with approximately 70% FAD occupancy in
purified protein (PMID:34646991). FAD binding is essential for the dehydrogenase function,
and ECSIT binding causes deflavination (PMID:33320993, PMID:38086790).
action: ACCEPT
reason: >-
ACAD9 binds FAD as a cofactor for its acyl-CoA dehydrogenase activity. The FAD content of
purified ACAD9 is approximately 70% (PMID:34646991), and ECSIT-mediated deflavination
switches ACAD9 from FAO enzyme to CI assembly factor (PMID:33320993).
supported_by:
- reference_id: PMID:34646991
supporting_text: "the FAD content of purified wild type ACAD9 protein (non-tagged ACAD9 and ACAD9-His6) was approximately 70%"
- reference_id: PMID:33320993
supporting_text: "interaction with ECSIT induces ACAD9 to eject its FAD cofactor from the catalytic site"
# --- Annotation 10: medium-chain fatty acyl-CoA dehydrogenase activity (IEA, ARBA) ---
- term:
id: GO:0070991
label: medium-chain fatty acyl-CoA dehydrogenase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
IEA annotation from ARBA/Rhea mapping based on EC 1.3.8.7. ACAD9 does have some activity
toward medium-chain substrates (C9-C11-CoA) as demonstrated in PMID:16020546. However,
its primary specificity is for long-chain substrates; medium-chain activity is lower and
secondary.
action: KEEP_AS_NON_CORE
reason: >-
While ACAD9 is primarily a long-chain ACAD, it does have experimentally demonstrated
medium-chain activity (PMID:16020546), and this is consistent with the EC 1.3.8.7
assignment in UniProt. The IEA annotation correctly reflects the catalogued EC number.
supported_by:
- reference_id: PMID:16020546
supporting_text: "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)"
# --- Annotation 11: very-long-chain fatty acyl-CoA dehydrogenase activity (IDA, PMID:33320993) ---
- term:
id: GO:0017099
label: very-long-chain fatty acyl-CoA dehydrogenase activity
evidence_type: IDA
original_reference_id: PMID:33320993
review:
summary: >-
IDA annotation from FlyBase based on Giachin et al. 2021, which characterized ACAD9 acyl-CoA
dehydrogenase activity using an ETF fluorescence reduction assay with palmitoyl-CoA (C16:0)
as substrate. While ACAD9 does have dehydrogenase activity, the term "very-long-chain"
(GO:0017099, typically C20+) may be an over-annotation. ACAD9's primary substrates are
long-chain (C14-C18), not very-long-chain. The activity measured in this paper used
palmitoyl-CoA (C16:0), which is a long-chain substrate.
action: MODIFY
reason: >-
ACAD9 has optimal activity with long-chain (C14-C18) substrates, not very-long-chain (C20+).
The paper PMID:33320993 demonstrated ACAD dehydrogenase activity using palmitoyl-CoA (C16:0),
which is a long-chain substrate. While ACAD9 does have some activity on C20:0 (eicosanoyl-CoA)
as shown in PMID:16020546, its primary specificity is long-chain. The annotation should be
modified to long-chain fatty acyl-CoA dehydrogenase activity (GO:0004466).
proposed_replacement_terms:
- id: GO:0004466
label: long-chain fatty acyl-CoA dehydrogenase activity
supported_by:
- reference_id: PMID:33320993
supporting_text: "After addition of the ACAD specific substrate palmitoyl-CoA (C16:0), there is a clear loss of ETF fluorescence in ACAD9 alone"
- reference_id: PMID:16020546
supporting_text: "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)"
# --- Annotation 12: very-long-chain fatty acyl-CoA dehydrogenase activity (IDA, PMID:34646991) ---
- term:
id: GO:0017099
label: very-long-chain fatty acyl-CoA dehydrogenase activity
evidence_type: IDA
original_reference_id: PMID:34646991
review:
summary: >-
IDA annotation from FlyBase based on Xia et al. 2021 (iScience). This paper characterized
ACAD9 enzymatic activity using palmitoyl-CoA (C16:0) as substrate and measured dehydrogenation
activity of 83 min-1. The activity is real but the term "very-long-chain" is an overstatement
of specificity, since palmitoyl-CoA is a long-chain substrate.
action: MODIFY
reason: >-
Same reasoning as above. ACAD9 has its optimal activity on long-chain substrates (C14-C18).
The paper PMID:34646991 used palmitoyl-CoA (C16:0) as substrate, which is long-chain.
The VLCAD-like annotation is misleading; ACAD9 activity is only 18% of VLCAD activity
(PMID:34646991).
proposed_replacement_terms:
- id: GO:0004466
label: long-chain fatty acyl-CoA dehydrogenase activity
supported_by:
- reference_id: PMID:34646991
supporting_text: "this activity is only 18% of VLCAD activity"
- reference_id: PMID:34646991
supporting_text: "As purified, the wild-type ACAD9 protein has a dehydrogenation activity of 83 min-1, attributable to the FAD-containing holo-form of the protein"
# --- Annotation 13: protein-macromolecule adaptor activity (IDA, PMID:32320651) ---
- term:
id: GO:0030674
label: protein-macromolecule adaptor activity
evidence_type: IDA
original_reference_id: PMID:32320651
review:
summary: >-
IDA annotation from FlyBase based on Formosa et al. 2020, which demonstrated that ACAD9
is a core component of the MCIA complex and acts as an adaptor linking ECSIT (and through it,
NDUFAF1) to CI assembly intermediates. The study showed ACAD9 forms a hierarchy of stability
centered on itself within the MCIA complex. This is an excellent annotation capturing ACAD9's
primary assembly factor role using a molecular function term.
action: ACCEPT
reason: >-
ACAD9 functions as a protein-macromolecule adaptor within the MCIA complex, bridging ECSIT
to CI assembly intermediates. This is well-supported by PMID:32320651, which showed that
knockout of ACAD9 destabilizes the entire MCIA complex, and by structural studies showing
ACAD9 provides binding surfaces for ECSIT via its vestigial dehydrogenase domain
(PMID:33320993, PMID:38086790). This annotation captures the core molecular function of
ACAD9 in CI assembly.
supported_by:
- reference_id: PMID:32320651
supporting_text: "while each MCIA component is critical for complex I assembly, a hierarchy of stability exists centered on ACAD9"
- reference_id: PMID:33320993
supporting_text: "ECSIT functions as the bridging node of the MCIA core complex"
# --- Annotation 14: mitochondrial complex I intermediate assembly complex (IDA, PMID:33320993) ---
- term:
id: GO:0160295
label: mitochondrial complex I intermediate assembly complex
evidence_type: IDA
original_reference_id: PMID:33320993
review:
summary: >-
IDA annotation from FlyBase based on Giachin et al. 2021. This study provided extensive
structural and biochemical evidence that ACAD9 is a core component of the MCIA complex,
including cryo-EM structures, SAXS, native MS, and SEC-MALLS data demonstrating stable
ACAD9-ECSIT complexes.
action: ACCEPT
reason: >-
ACAD9 is unequivocally a component of the MCIA complex. Giachin et al. demonstrated
formation of the ACAD9-ECSIT binary complex by multiple biophysical methods and showed
ECSIT binds the vestigial dehydrogenase domain of ACAD9 (PMID:33320993). This is a core
annotation for ACAD9.
supported_by:
- reference_id: PMID:33320993
supporting_text: "ECSIT functions as the bridging node of the MCIA core complex"
- reference_id: PMID:33320993
supporting_text: "the C-terminal domain of ECSIT directly binds to the vestigial dehydrogenase domain of the FAO enzyme ACAD9 and induces its deflavination"
# --- Annotation 15: mitochondrial complex I intermediate assembly complex (IDA, PMID:34646991) ---
- term:
id: GO:0160295
label: mitochondrial complex I intermediate assembly complex
evidence_type: IDA
original_reference_id: PMID:34646991
review:
summary: >-
IDA annotation from FlyBase based on Xia et al. 2021 (iScience). This study reconstituted
the ACAD9/ECSIT/NDUFAF1 ternary complex in vitro and characterized it by SEC, SAXS, and
pull-down assays, demonstrating ACAD9 is a core member of the MCIA complex.
action: ACCEPT
reason: >-
Xia et al. provided direct biochemical evidence for ACAD9 as part of the MCIA ternary
complex with ECSIT and NDUFAF1, including purification of the stable ternary complex with
1:1:1 stoichiometry (PMID:34646991). This is strong supporting evidence for the CC annotation.
supported_by:
- reference_id: PMID:34646991
supporting_text: "ACAD9, ECSIT, and NDUFAF1 form the core mitochondrial CI assembly (MCIA) complex"
- reference_id: PMID:34646991
supporting_text: "mixing of the three purified, individual proteins forms a ternary complex, ACAD9/ECSIT/NDUFAF1, with a 1:1:1 molar (monomer) ratio"
# --- Annotation 16: mitochondrion (IDA, GO_REF:0000052, HPA) ---
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IDA
original_reference_id: GO_REF:0000052
review:
summary: >-
IDA annotation from HPA based on immunofluorescence data. ACAD9 localization to
mitochondria is well-established across multiple studies and methods.
action: ACCEPT
reason: >-
ACAD9 mitochondrial localization is confirmed by multiple independent approaches:
submitochondrial fractionation (PMID:16020546), immunofluorescence (PMID:20816094),
and proteomics (PMID:34800366). The HPA immunofluorescence data is consistent with
this body of evidence.
supported_by:
- reference_id: PMID:16020546
supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"
# --- Annotation 17: mitochondrial complex I intermediate assembly complex (IDA, PMID:32320651) ---
- term:
id: GO:0160295
label: mitochondrial complex I intermediate assembly complex
evidence_type: IDA
original_reference_id: PMID:32320651
review:
summary: >-
IDA annotation from FlyBase based on Formosa et al. 2020. This study used cell knockout
studies of each MCIA component and demonstrated that ACAD9 is central to MCIA complex
stability, also identifying TMEM186 and COA1 as additional MCIA components.
action: ACCEPT
reason: >-
Formosa et al. provided strong genetic evidence from knockout studies that ACAD9 is a
core component of the MCIA complex, with a central role in maintaining complex stability.
Loss of ACAD9 resulted in destabilization of the entire MCIA complex and impaired CI
assembly (PMID:32320651).
supported_by:
- reference_id: PMID:32320651
supporting_text: "The mitochondrial complex I intermediate assembly (MCIA) complex, containing assembly factors NDUFAF1, ECSIT, ACAD9, and TMEM126B, is required for building the intermediate ND2-module"
- reference_id: PMID:32320651
supporting_text: "while each MCIA component is critical for complex I assembly, a hierarchy of stability exists centered on ACAD9"
# --- Annotation 18: acyl-CoA dehydrogenase activity (IDA, PMID:38086790) ---
- term:
id: GO:0003995
label: acyl-CoA dehydrogenase activity
evidence_type: IDA
original_reference_id: PMID:38086790
review:
summary: >-
IDA annotation from FlyBase based on McGregor et al. 2023 (Nature Communications). This
study determined a 3.0 A cryo-EM structure of the ACAD9-ECSIT complex and also characterized
ACAD9 dehydrogenase activity using the ETF fluorescence reduction assay with palmitoyl-CoA.
The study demonstrated ECSIT binding induces a large conformational change in the FAD-binding
loop of ACAD9, releasing FAD and converting ACAD9 from an FAO enzyme to a CI assembly factor.
action: ACCEPT
reason: >-
McGregor et al. directly measured ACAD9 acyl-CoA dehydrogenase activity via ETF fluorescence
reduction assay and confirmed the deflavination mechanism (PMID:38086790). This provides
direct experimental evidence for ACAD9's enzymatic function.
supported_by:
- reference_id: PMID:38086790
supporting_text: "ECSIT binding induces a major conformational change in the FAD-binding loop of ACAD9, releasing the FAD cofactor and converting ACAD9 from a fatty acid beta-oxidation (FAO) enzyme to a CI assembly factor"
# --- Annotation 19: mitochondrial inner membrane (NAS, PMID:32320651) ---
- term:
id: GO:0005743
label: mitochondrial inner membrane
evidence_type: NAS
original_reference_id: PMID:32320651
review:
summary: >-
NAS annotation from ComplexPortal based on PMID:32320651. ACAD9 functions as part of the
MCIA complex at the mitochondrial inner membrane where CI assembly occurs. This is
consistent with the experimentally determined localization.
action: ACCEPT
reason: >-
ACAD9 is localized to the mitochondrial inner membrane, matrix side, as a peripheral
membrane protein. This is well-supported by fractionation studies (PMID:16020546) and
is the site of its CI assembly function as part of the MCIA complex (PMID:32320651).
supported_by:
- reference_id: PMID:16020546
supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"
# --- Annotation 20: mitochondrial respiratory chain complex I assembly (NAS, PMID:32320651) ---
- term:
id: GO:0032981
label: mitochondrial respiratory chain complex I assembly
evidence_type: NAS
original_reference_id: PMID:32320651
review:
summary: >-
NAS annotation from ComplexPortal based on Formosa et al. 2020. ACAD9 is essential for
CI assembly as a core member of the MCIA complex. This is the primary biological process
annotation for ACAD9 and represents its most important physiological function.
action: ACCEPT
reason: >-
CI assembly is the primary biological process function of ACAD9. Multiple studies demonstrate
that loss of ACAD9 causes isolated CI deficiency (PMID:20816094), ACAD9 is part of the
MCIA complex required for ND2-module assembly (PMID:32320651), and disease mutations
cluster in the assembly domain (PMID:20816094).
additional_reference_ids:
- file:human/ACAD9/ACAD9-deep-research-falcon.md
supported_by:
- reference_id: PMID:32320651
supporting_text: "The mitochondrial complex I intermediate assembly (MCIA) complex, containing assembly factors NDUFAF1, ECSIT, ACAD9, and TMEM126B, is required for building the intermediate ND2-module"
- reference_id: PMID:20816094
supporting_text: "ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required for the assembly of complex I"
- reference_id: file:human/ACAD9/ACAD9-deep-research-falcon.md
supporting_text: "its dominant essential role is as a CI assembly factor within MCIA."
# --- Annotation 21: mitochondrion (HTP, PMID:34800366) ---
- term:
id: GO:0005739
label: mitochondrion
evidence_type: HTP
original_reference_id: PMID:34800366
review:
summary: >-
HTP annotation from high-throughput human mitochondrial proteome study (Morgenstern et al.
2021). ACAD9 was identified as a high-confidence mitochondrial protein. This is consistent
with extensive prior evidence.
action: ACCEPT
reason: >-
ACAD9 is a well-established mitochondrial protein. Its identification in a quantitative
high-confidence mitochondrial proteome study (PMID:34800366) adds further confirmation
to established knowledge from targeted studies (PMID:16020546, PMID:20816094).
supported_by:
- reference_id: PMID:16020546
supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"
# --- Annotation 22: protein binding (IPI, PMID:33753518) ---
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33753518
review:
summary: >-
IPI annotation based on Carroll et al. 2021, which showed TMEM70 and TMEM242 interact
with MCIA complex components including ACAD9. The WITH field includes UniProtKB:Q8IUX1
(TMEM242), Q9BQ95 (TMEM126B), Q9BUB7 (TMEM70), and Q9Y375 (NDUFAF1). While the
interactions are real and informative, the term 'protein binding' is uninformative.
The adaptor activity annotation (GO:0030674) already captures the functionally relevant
aspect.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The protein binding term is uninformative. The ACAD9 interactions with TMEM70 and TMEM242
are real (PMID:33753518), but this function is better captured by the protein-macromolecule
adaptor activity annotation (GO:0030674) and the MCIA complex membership (GO:0160295).
Generic 'protein binding' does not tell us anything about the actual function of ACAD9.
supported_by:
- reference_id: PMID:33753518
supporting_text: "TMEM70 and TMEM242 interact with the mitochondrial complex I assembly (the MCIA) complex that supports assembly of the membrane arm of complex I"
# --- Annotation 23: protein binding (IPI, PMID:32320651) ---
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32320651
review:
summary: >-
IPI annotation based on Formosa et al. 2020. The WITH field includes TMEM126B (Q96B77),
ECSIT (Q9BQ95), TMEM186 (Q9GZY4), and NDUFAF1 (Q9Y375). These are the MCIA complex
interactions. While real, 'protein binding' is uninformative.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Same as above. The interactions with MCIA complex components are real and well-characterized
(PMID:32320651), but 'protein binding' is uninformative. The adaptor activity (GO:0030674)
and MCIA complex membership (GO:0160295) annotations are more informative.
supported_by:
- reference_id: PMID:32320651
supporting_text: "The mitochondrial complex I intermediate assembly (MCIA) complex, containing assembly factors NDUFAF1, ECSIT, ACAD9, and TMEM126B, is required for building the intermediate ND2-module"
# --- Annotation 24: long-chain fatty acid metabolic process (IDA, PMID:16020546) ---
- term:
id: GO:0001676
label: long-chain fatty acid metabolic process
evidence_type: IDA
original_reference_id: PMID:16020546
review:
summary: >-
IDA annotation from BHF-UCL based on Ensenauer et al. 2005. ACAD9 participates in
long-chain fatty acid beta-oxidation, with maximal activity toward long-chain unsaturated
acyl-CoA substrates (C16:1, C18:1, C18:2, C22:6). This is a secondary/moonlighting
function but is experimentally well-supported.
action: KEEP_AS_NON_CORE
reason: >-
While ACAD9 does participate in long-chain fatty acid metabolism, this represents a
secondary/moonlighting function. The primary in vivo role is CI assembly (PMID:20816094).
Disease mutations cause CI deficiency rather than primary FAO defects (PMID:20816094).
However, FAO activity is tissue-relevant especially in brain where ACAD9 is the main
long-chain ACAD (PMID:16020546, PMID:17564966).
supported_by:
- reference_id: PMID:16020546
supporting_text: "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)"
- reference_id: PMID:20816094
supporting_text: "ACAD9 mutations result in complex I deficiency and not in disturbed long-chain fatty acid oxidation"
# --- Annotation 25: long-chain fatty acyl-CoA dehydrogenase activity (IDA, PMID:16020546) ---
- term:
id: GO:0004466
label: long-chain fatty acyl-CoA dehydrogenase activity
evidence_type: IDA
original_reference_id: PMID:16020546
review:
summary: >-
IDA annotation from BHF-UCL based on Ensenauer et al. 2005. ACAD9 was purified, expressed,
and its substrate utilization pattern characterized, demonstrating maximal activity with
long-chain (C16-C18) unsaturated acyl-CoA substrates. This is the most appropriate
specific MF term for ACAD9's enzymatic activity.
action: ACCEPT
reason: >-
ACAD9 has well-characterized long-chain acyl-CoA dehydrogenase activity with Km values
of 2.8 uM for hexadecanoyl-CoA and 0.7 uM for (9Z)-hexadecenoyl-CoA (PMID:16020546).
This is the correct level of specificity for ACAD9's enzymatic function.
supported_by:
- reference_id: PMID:16020546
supporting_text: "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)"
# --- Annotation 26: mitochondrion (IDA, PMID:16020546) ---
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IDA
original_reference_id: PMID:16020546
review:
summary: >-
IDA annotation from BHF-UCL based on Ensenauer et al. 2005. Submitochondrial fractionation
studies confirmed ACAD9 is associated with the mitochondrial membrane.
action: ACCEPT
reason: >-
Direct experimental evidence from submitochondrial fractionation demonstrates ACAD9
is a mitochondrial protein associated with mitochondrial membranes (PMID:16020546).
supported_by:
- reference_id: PMID:16020546
supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"
# --- Annotation 27: mitochondrial membrane (IDA, PMID:16020546) ---
- term:
id: GO:0031966
label: mitochondrial membrane
evidence_type: IDA
original_reference_id: PMID:16020546
review:
summary: >-
IDA annotation from BHF-UCL based on Ensenauer et al. 2005. Submitochondrial fractionation
showed ACAD9 is membrane-associated. This is less specific than the inner membrane annotation
but still correct based on the fractionation data.
action: ACCEPT
reason: >-
ACAD9 is a peripheral membrane protein associated with the mitochondrial inner membrane
on the matrix side (PMID:16020546). The mitochondrial membrane annotation is correct,
though the more specific inner membrane annotation is also present.
supported_by:
- reference_id: PMID:16020546
supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"
# --- Annotation 28: medium-chain fatty acid metabolic process (IDA, PMID:16020546) ---
- term:
id: GO:0051791
label: medium-chain fatty acid metabolic process
evidence_type: IDA
original_reference_id: PMID:16020546
review:
summary: >-
IDA annotation from BHF-UCL based on Ensenauer et al. 2005. ACAD9 shows some activity
toward medium-chain substrates (C9-C11-CoA) in addition to its primary long-chain
specificity. This is a secondary activity.
action: KEEP_AS_NON_CORE
reason: >-
ACAD9 does have some medium-chain acyl-CoA dehydrogenase activity (PMID:16020546), but
its primary enzymatic specificity is for long-chain substrates, and its primary biological
role is CI assembly. Medium-chain FAO is a minor secondary activity, better handled by
MCAD in vivo.
supported_by:
- reference_id: PMID:16020546
supporting_text: "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)"
# --- Annotation 29: medium-chain fatty acyl-CoA dehydrogenase activity (IDA, PMID:16020546) ---
- term:
id: GO:0070991
label: medium-chain fatty acyl-CoA dehydrogenase activity
evidence_type: IDA
original_reference_id: PMID:16020546
review:
summary: >-
IDA annotation from BHF-UCL based on Ensenauer et al. 2005. ACAD9 shows activity toward
some medium-chain substrates in the C9-C11 range. While less active than on long-chain
substrates, this has been directly demonstrated experimentally.
action: KEEP_AS_NON_CORE
reason: >-
ACAD9 does have demonstrable medium-chain acyl-CoA dehydrogenase activity (PMID:16020546),
though this is secondary to its long-chain specificity and far secondary to its CI assembly
role. The activity is real but minor compared to dedicated MCAD.
supported_by:
- reference_id: PMID:16020546
supporting_text: "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)"
# --- Annotation 30: mitochondrial inner membrane (TAS, Reactome:R-HSA-6799179) ---
- term:
id: GO:0005743
label: mitochondrial inner membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6799179
review:
summary: >-
TAS annotation from Reactome pathway "Peripheral arm subunits bind the 815kDa complex to
form a 980kDa complex". ACAD9 functions at the mitochondrial inner membrane as part of the
MCIA complex during CI biogenesis.
action: ACCEPT
reason: >-
ACAD9 is localized to the mitochondrial inner membrane where CI assembly takes place.
This is well-supported experimentally (PMID:16020546, PMID:20816094) and the Reactome
annotation correctly reflects this.
supported_by:
- reference_id: PMID:16020546
supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"
# --- Annotation 31: mitochondrial inner membrane (TAS, Reactome:R-HSA-6799196) ---
- term:
id: GO:0005743
label: mitochondrial inner membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6799196
review:
summary: >-
TAS annotation from Reactome pathway "The MCIA complex, NDUFAF2-7 all dissociate from the
980kDa complex, resulting in Complex I". Consistent with ACAD9's role as an MCIA assembly
factor at the inner membrane.
action: ACCEPT
reason: >-
Same as above. ACAD9 is at the mitochondrial inner membrane and this Reactome step
describes MCIA complex dissociation after CI assembly is complete. Well-supported
experimentally.
supported_by:
- reference_id: PMID:16020546
supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"
# --- Annotation 32: mitochondrial inner membrane (TAS, Reactome:R-HSA-6799197) ---
- term:
id: GO:0005743
label: mitochondrial inner membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6799197
review:
summary: >-
TAS annotation from Reactome pathway "ND4, ND5 bind the 550kDa complex to form the 815kDa
complex". Another step in CI biogenesis at the inner membrane.
action: ACCEPT
reason: >-
Consistent with ACAD9's role as an MCIA assembly factor at the mitochondrial inner membrane.
supported_by:
- reference_id: PMID:16020546
supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"
# --- Annotation 33: mitochondrial inner membrane (TAS, Reactome:R-HSA-6799199) ---
- term:
id: GO:0005743
label: mitochondrial inner membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6799199
review:
summary: >-
TAS annotation from Reactome pathway "COA1:MT-ND2, TMEM186:MT-ND3, MT-ND6, NDUFB6 bind
the MCIA complex to form a 370kDa subcomplex". This step directly involves the MCIA complex
of which ACAD9 is a core member.
action: ACCEPT
reason: >-
ACAD9 is a core member of the MCIA complex that participates in this assembly step.
Well-supported by PMID:32320651.
supported_by:
- reference_id: PMID:32320651
supporting_text: "The mitochondrial complex I intermediate assembly (MCIA) complex, containing assembly factors NDUFAF1, ECSIT, ACAD9, and TMEM126B, is required for building the intermediate ND2-module"
# --- Annotation 34: mitochondrial inner membrane (TAS, Reactome:R-HSA-6799202) ---
- term:
id: GO:0005743
label: mitochondrial inner membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6799202
review:
summary: >-
TAS annotation from Reactome pathway "The 315kDa subcomplex binds the 370kDa subcomplex
to form the 550kDa complex". Another CI assembly step at the inner membrane.
action: ACCEPT
reason: >-
Consistent with ACAD9's role as an MCIA assembly factor at the mitochondrial inner membrane.
supported_by:
- reference_id: PMID:16020546
supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"
# --- Annotation 35: protein binding (IPI, PMID:20816094) ---
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:20816094
review:
summary: >-
IPI annotation based on Nouws et al. 2010, which showed ACAD9 interacts with NDUFAF1
(Q9Y375) and ECSIT (Q9BQ95). These are the foundational interactions establishing ACAD9
as an MCIA complex member. However, 'protein binding' is uninformative.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The interactions demonstrated by Nouws et al. (PMID:20816094) are central to understanding
ACAD9's CI assembly function, but the generic 'protein binding' term fails to capture the
biological significance. The adaptor activity (GO:0030674) and MCIA complex membership
(GO:0160295) annotations are far more informative.
supported_by:
- reference_id: PMID:20816094
supporting_text: "ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required for the assembly of complex I"
# --- Annotation 36: mitochondrion (IDA, PMID:20816094) ---
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IDA
original_reference_id: PMID:20816094
review:
summary: >-
IDA annotation based on Nouws et al. 2010. ACAD9 was shown to localize to mitochondria
as part of the study establishing its role in CI assembly.
action: ACCEPT
reason: >-
ACAD9 mitochondrial localization is well-established and confirmed in this study
(PMID:20816094) which demonstrated ACAD9 interactions with mitochondrial CI assembly
factors.
supported_by:
- reference_id: PMID:20816094
supporting_text: "ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required for the assembly of complex I"
# --- Annotation 37: mitochondrial respiratory chain complex I assembly (IMP, PMID:20816094) ---
- term:
id: GO:0032981
label: mitochondrial respiratory chain complex I assembly
evidence_type: IMP
original_reference_id: PMID:20816094
review:
summary: >-
IMP annotation based on Nouws et al. 2010. This landmark study demonstrated that ACAD9
mutations result in CI deficiency (not FAO deficiency), establishing CI assembly as ACAD9's
primary function. ACAD9 knockdown/mutation leads to impaired CI assembly. This is the
strongest evidence for ACAD9's primary biological process.
action: ACCEPT
reason: >-
Nouws et al. provided the foundational evidence that ACAD9 is required for CI biogenesis,
showing that ACAD9 mutations cause CI deficiency rather than FAO defects, and that ACAD9
interacts with known CI assembly factors NDUFAF1 and ECSIT (PMID:20816094). This IMP
annotation is the most critical biological process annotation for ACAD9.
supported_by:
- reference_id: PMID:20816094
supporting_text: "ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required for the assembly of complex I"
- reference_id: PMID:20816094
supporting_text: "ACAD9 mutations result in complex I deficiency and not in disturbed long-chain fatty acid oxidation"
# --- Annotation 38: nucleus (IDA, PMID:21237683) ---
- term:
id: GO:0005634
label: nucleus
evidence_type: IDA
original_reference_id: PMID:21237683
review:
summary: >-
IDA annotation based on He et al. 2011. This study characterized new long-chain ACADs
including ACAD9, ACAD10, and ACAD11, and reported ACAD9 in the nucleus. However, ACAD9
is a mitochondrial protein with a mitochondrial transit peptide, and all functional studies
place it in mitochondria. Nuclear localization is likely an artifact of overexpression or
immunostaining cross-reactivity and is not supported by the consensus of literature.
action: REMOVE
reason: >-
ACAD9 has a mitochondrial transit peptide (residues 1-37, cleaved upon import; PMID:16020546)
and all functional characterization places it in mitochondria. The nuclear localization
reported in PMID:21237683 is not supported by other studies and is likely artifactual.
UniProt does not include nuclear localization. The extensive proteomics and fractionation
data consistently place ACAD9 in mitochondria only.
supported_by:
- reference_id: PMID:16020546
supporting_text: "A 37-amino acid leader peptide was cleaved sequentially by two mitochondrial peptidases to yield a predicted molecular mass of 65 kDa for the mature subunit"
# --- Annotation 39: dendrite (IDA, PMID:21237683) ---
- term:
id: GO:0030425
label: dendrite
evidence_type: IDA
original_reference_id: PMID:21237683
review:
summary: >-
IDA annotation based on He et al. 2011. The study examined ACAD expression patterns in
human cerebellum and found ACAD9 was highly expressed in the granular layer. The dendrite
annotation likely reflects immunohistochemical staining of neuronal processes. However,
this is a cell-type expression pattern rather than a specific subcellular localization
to dendrites. The protein within those cells is still in mitochondria.
action: REMOVE
reason: >-
ACAD9 is a mitochondrial matrix-facing protein. Finding it in neurons (including dendritic
processes) reflects tissue expression (ACAD9 is highly expressed in cerebellum) rather than
specific dendritic localization. The protein is in mitochondria within dendrites, not in
the dendritic cytoplasm. This annotation conflates cell-type expression with subcellular
localization.
supported_by:
- reference_id: PMID:21237683
supporting_text: "ACAD9 was most highly expressed in the granular layer"
- reference_id: PMID:16020546
supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"
# --- Annotation 40: mitochondrion (IDA, GO_REF:0000054, LIFEdb) ---
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IDA
original_reference_id: GO_REF:0000054
review:
summary: >-
IDA annotation from LIFEdb based on expressed fusion protein localization in living cells.
ACAD9 localization to mitochondria was confirmed, consistent with all other evidence.
action: ACCEPT
reason: >-
ACAD9 mitochondrial localization is well-established. The LIFEdb fusion protein experiment
confirms what is known from multiple other approaches (PMID:16020546, PMID:20816094,
PMID:34800366).
supported_by:
- reference_id: PMID:16020546
supporting_text: "Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane"
# --- NEW annotations not currently in GOA ---
# --- Annotation 41: NEW - fatty acid beta-oxidation (BP) ---
- term:
id: GO:0006635
label: fatty acid beta-oxidation
evidence_type: IDA
original_reference_id: PMID:16020546
review:
summary: >-
ACAD9 catalyzes the first step of mitochondrial fatty acid beta-oxidation, the
alpha,beta-dehydrogenation of long-chain fatty acyl-CoA substrates. This specific
biological process term is not currently annotated but is more precise than the existing
GO:0006631 (fatty acid metabolic process) and GO:0001676 (long-chain fatty acid metabolic
process) annotations.
action: NEW
reason: >-
ACAD9 directly catalyzes the first step of the beta-oxidation cycle. The existing BP
annotations (GO:0006631 fatty acid metabolic process, GO:0001676 long-chain fatty acid
metabolic process) are correct but the more specific fatty acid beta-oxidation term is
warranted given the direct experimental evidence. This is ACAD9's secondary core function.
supported_by:
- reference_id: PMID:16020546
supporting_text: "Human acyl-CoA dehydrogenase-9 plays a novel role in the mitochondrial beta-oxidation of unsaturated fatty acids"
- reference_id: PMID:34646991
supporting_text: "ACAD9 was first identified as a member of the acyl-CoA dehydrogenase family catalyzing the alpha, beta-dehydrogenation of fatty acyl-CoA thioesters, the first step of the fatty acid beta-oxidation cycle"
core_functions:
- molecular_function:
id: GO:0030674
label: protein-macromolecule adaptor activity
directly_involved_in:
- id: GO:0032981
label: mitochondrial respiratory chain complex I assembly
locations:
- id: GO:0005743
label: mitochondrial inner membrane
in_complex:
id: GO:0160295
label: mitochondrial complex I intermediate assembly complex
description: >-
Primary function. ACAD9 is a core component of the MCIA complex, functioning as a
protein-macromolecule adaptor that bridges ECSIT (and through ECSIT, NDUFAF1) to CI assembly
intermediates. ECSIT binding triggers deflavination and a conformational switch from FAO enzyme
to assembly factor. Disease mutations causing CI deficiency (MC1DN20) underscore this as the
essential role.
supported_by:
- reference_id: PMID:20816094
supporting_text: "ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required for the assembly of complex I"
- reference_id: PMID:32320651
supporting_text: "while each MCIA component is critical for complex I assembly, a hierarchy of stability exists centered on ACAD9"
- reference_id: PMID:38086790
supporting_text: "ECSIT binding induces a major conformational change in the FAD-binding loop of ACAD9, releasing the FAD cofactor and converting ACAD9 from a fatty acid beta-oxidation (FAO) enzyme to a CI assembly factor"
- molecular_function:
id: GO:0004466
label: long-chain fatty acyl-CoA dehydrogenase activity
directly_involved_in:
- id: GO:0006635
label: fatty acid beta-oxidation
locations:
- id: GO:0005743
label: mitochondrial inner membrane
description: >-
Secondary/moonlighting function. ACAD9 retains FAD-dependent acyl-CoA dehydrogenase activity
(EC 1.3.8.8) toward long-chain fatty acyl-CoA substrates, catalyzing the first step of
mitochondrial fatty acid beta-oxidation. Its activity is approximately 18% that of VLCAD. This
function is mutually exclusive with the CI assembly role (ECSIT binding causes deflavination).
ACAD9's FAO role is particularly relevant in tissues where it is the main long-chain ACAD, such
as the CNS.
supported_by:
- reference_id: PMID:16020546
supporting_text: "Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA)"
- reference_id: PMID:34646991
supporting_text: "this activity is only 18% of VLCAD activity"
proposed_new_terms: []
suggested_questions:
- question: >-
What is the relative abundance of ACAD9 in its FAO (holo, FAD-bound) vs. CI assembly
(apo, ECSIT-bound) states in different human tissues? Current understanding is based
primarily on in vitro reconstitution, and the relative partitioning between FAO and
assembly functions in vivo remains poorly quantified.
- question: >-
Is there evidence that ACAD9 FAO function contributes to disease severity in ACAD9
deficiency, beyond the CI assembly defect? Schiff et al. 2015 suggested both CI assembly
and FAO enzyme activity contribute to disease severity, but the relative contribution
remains debated.
suggested_experiments:
- description: >-
Quantitative proteomics to measure the fraction of ACAD9 in ECSIT-bound (assembly) vs.
free (FAO-competent) states across human tissues, especially brain regions. This would
clarify the in vivo partitioning of ACAD9 between its two mutually exclusive functions.
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO terms
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000043
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
findings: []
- id: GO_REF:0000044
title: >-
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary
mapping, accompanied by conservative changes to GO terms applied by UniProt
findings: []
- id: GO_REF:0000052
title: Gene Ontology annotation based on curation of immunofluorescence data
findings: []
- id: GO_REF:0000054
title: >-
Gene Ontology annotation based on curation of intracellular localizations of expressed
fusion proteins in living cells
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:16020546
title: >-
Human acyl-CoA dehydrogenase-9 plays a novel role in the mitochondrial beta-oxidation
of unsaturated fatty acids.
findings:
- statement: >-
ACAD9 is a mitochondrial membrane-associated homodimer with long-chain acyl-CoA
dehydrogenase activity, maximal toward unsaturated C16-C22 substrates.
supporting_text: >-
Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs
as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA).
- id: PMID:20816094
title: >-
Acyl-CoA dehydrogenase 9 is required for the biogenesis of oxidative phosphorylation
complex I.
findings:
- statement: >-
ACAD9 binds CI assembly factors NDUFAF1 and ECSIT and is specifically required for CI
assembly. ACAD9 mutations cause CI deficiency, not FAO defects.
supporting_text: >-
ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required
for the assembly of complex I. Furthermore, ACAD9 mutations result in complex I
deficiency and not in disturbed long-chain fatty acid oxidation.
- id: PMID:21237683
title: Identification and characterization of new long chain acyl-CoA dehydrogenases.
findings:
- statement: >-
ACAD9 is highly expressed in human cerebellum (granular layer), where ACADV is not found,
suggesting tissue-specific roles in long-chain FAO.
supporting_text: >-
ACAD9 was most highly expressed in the granular layer, ACAD11 in the white matter,
and MCAD in the molecular layer and axons of specific neurons.
- id: PMID:24158852
title: >-
ACAD9, a complex I assembly factor with a moonlighting function in fatty acid oxidation
deficiencies.
findings:
- statement: >-
The CI assembly function of ACAD9 is independent of its FAO activity. The E426Q catalytic
mutant abolishes dehydrogenase activity but does not affect CI assembly.
supporting_text: >-
Catalytically inactive ACAD9 gave partial-to-complete rescue of complex I
biogenesis in ACAD9-deficient cells
- id: PMID:32320651
title: >-
Dissecting the Roles of Mitochondrial Complex I Intermediate Assembly Complex Factors in
the Biogenesis of Complex I.
findings:
- statement: >-
ACAD9 is a core member of the MCIA complex (with NDUFAF1, ECSIT, TMEM126B) required for
ND2-module assembly. A hierarchy of stability exists centered on ACAD9. TMEM186 and COA1
are additional MCIA components.
supporting_text: >-
while each MCIA component is critical for complex I assembly, a hierarchy of stability
exists centered on ACAD9.
- id: PMID:33320993
title: >-
Assembly of The Mitochondrial Complex I Assembly Complex Suggests a Regulatory Role for
Deflavination.
findings:
- statement: >-
ECSIT C-terminal domain binds the vestigial dehydrogenase domain of ACAD9 and induces
deflavination, switching ACAD9 from an FAO enzyme to a CI assembly factor. Cryo-EM
confirmed the FAD binding site is empty in the ECSIT-bound state.
supporting_text: >-
interaction with ECSIT induces ACAD9 to eject its FAD cofactor from the catalytic site.
- id: PMID:33753518
title: >-
TMEM70 and TMEM242 help to assemble the rotor ring of human ATP synthase and interact
with assembly factors for complex I.
findings:
- statement: >-
TMEM70 and TMEM242 interact with MCIA complex components including ACAD9, ECSIT,
NDUFAF1, and TMEM126B.
supporting_text: >-
When TMEM242-t and similarly tagged TMEM70 (TMEM70-t) were expressed separately in
HEK293 cells, the most significantly associated proteins were ACAD9 (acyl-CoA
dehydrogenase family member 9), ECSIT (evolutionarily conserved signaling intermediate
in Toll pathway), and NDUFAF1 (NADH:ubiquinone oxidoreductase complex assembly factor 1)
- id: PMID:34646991
title: >-
Molecular mechanism of interactions between ACAD9 and binding partners in mitochondrial
respiratory complex I assembly.
findings:
- statement: >-
ACAD9, ECSIT, and NDUFAF1 form a stable 1:1:1 ternary complex. ECSIT binds at the ETF
binding site in ACAD9's N-terminal domain, explaining the mutual exclusivity of FAO and
assembly functions. ACAD9 activity is only 18% of VLCAD.
supporting_text: >-
this activity is only 18% of VLCAD activity
- id: PMID:34800366
title: >-
Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular
context.
findings:
- statement: >-
ACAD9 was identified as a high-confidence member of the human mitochondrial proteome.
supporting_text: >-
We classified >8,000 proteins in mitochondrial preparations of human cells and
defined a mitochondrial high-confidence proteome of >1,100 proteins (MitoCoP).
- id: PMID:38086790
title: >-
The assembly of the Mitochondrial Complex I Assembly complex uncovers a redox pathway
coordination.
findings:
- statement: >-
3.0 A cryo-EM structure of ACAD9-ECSIT complex revealed a 15-residue ECSIT peptide
(res 320-334) that inserts at the junction of ACAD9 dehydrogenase and vestigial domains.
ECSIT binding induces a 10 A gatekeeper loop movement in ACAD9, releasing FAD. ECSIT
phosphorylation downregulates its association with ACAD9 and is reduced upon amyloid-beta
exposure.
supporting_text: >-
ECSIT binding induces a major conformational change in the FAD-binding loop of ACAD9,
releasing the FAD cofactor and converting ACAD9 from a fatty acid beta-oxidation (FAO)
enzyme to a CI assembly factor.
- id: Reactome:R-HSA-6799179
title: Peripheral arm subunits bind the 815kDa complex to form a 980kDa complex
findings: []
- id: Reactome:R-HSA-6799196
title: >-
The MCIA complex, NDUFAF2-7 all dissociate from the 980kDa complex, resulting in Complex I
findings: []
- id: Reactome:R-HSA-6799197
title: ND4, ND5 bind the 550kDa complex to form the 815kDa complex
findings: []
- id: Reactome:R-HSA-6799199
title: >-
COA1:MT-ND2, TMEM186:MT-ND3, MT-ND6, NDUFB6 bind the MCIA complex to form a 370kDa
subcomplex
findings: []
- id: Reactome:R-HSA-6799202
title: The 315kDa subcomplex binds the 370kDa subcomplex to form the 550kDa complex
findings: []